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Abstract
Many important processes in cells are controlled by extracellular signals which are
caused by many different chemical signals from their surrounding. Cells have the
capability to react to signal transduction in an appropriate way, such as activate the
response of intracellular molecules, which is mainly governed by proteins reacting
with each other.
Intracellular signalling networks are mainly based on kinases and phosphatases, en-
zymes which control phosphorylation and dephosphorylation of other enzymes in the
cellular surrounding to the nucleus.
In this thesis we present mathematical models for negative feedback signal transduc-
tion processes. Signal transduction pathways are often equipped with negative feed-
backs. Negative feedback loops are important components that exhibit oscillations
in concentrations of the substances involved, both temporally and spatially. These
feedbacks constitute a major research for targeted therapies in cancer treatment, drug
action and cause cross-activation of other pathways. Specifically, we investigate sys-
tematically how the negative feedback structure of the signal transduction network can
transmit information despite noise in protein levels. In this thesis, we consider mathe-
matical models of the Hes1, Hes1-Stat3 and p53-Mdm2 pathways.
In chapter 3, we have undertaken a detailed study of the previous work done in the field.
viii
Building on this previous work, we derive mathematical models (systems of partial dif-
ferential equations) to capture the evolution in space and time of the key variables in
the Hes1 and p53-Mdm2 systems. Computational simulations allow us to show that
our reaction-diffusion models are able to produce sustained oscillations both spatially
and temporally. The simulations of our models also allow us to calculate a diffusion
coefficient range for the variables in each mRNA and protein, as well as ranges for
other key parameters of the models. Also, we have carried out simulations under dif-
ferent conditions such as considering a time delay in the protein diffusion process from
nucleus to the cytoplasm, varying the thickness of the nucleus membrane which slows
down diffusion in a cell. Our results have extended and generalized previous work in
this area.
All the mathematical models in this thesis use the numerical analysis of nonlinear
partial differential equations and computational simulations to obtain insight into the
underlying biological systems. The systems of nonlinear partial differential equations
were solved numerically using one of the MATLAB, COMSOL and URDME software
packages.
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Chapter 1
Introduction
Signal transduction plays a vital role in many intracellular processes such as eukaryotic
chemotaxis, polarity generation, cell division. The correct localisation of transcription
factors is vitally important for the proper functioning of many intracellular signalling
pathways. Experimental data has shown that many pathways exhibit oscillations in
concentrations of the substances involved, both temporally and spatially. Negative
feedback loops are important components of these oscillations, providing fine regula-
tion for the factors involved. Negative feedback loops controlling the concentrations
of key intracellular proteins are prevalent in a diverse range of important cellular pro-
cesses. Mathematical models can help us to better understand these interactions. In this
thesis we consider mathematical models of two such pathways: Hes1 and p53-Mdm2.
The chapters of the thesis are organised as follows:
Chapter 2 is a biological overview of the cell cycle and intracellular signal transduc-
tion pathways, in particular, negative feedback systems. The aim of this chapter is to
give some basic information of the main components of the cell cycle, the important
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processes of transcription and translation, a description of some important transcrip-
tion factors (p53, STAT3, Hes1 and the interactions among them), tumour suppressor
genes and cancer.
In chapter 3, we present a literature review of the modelling of a number of specific
intracellular and intercellular processes in time. One set of efforts has dealt with mod-
eling the fundamental regulatory activity of the cell, controlled at the level of enzymes
and genes. Also the models discuss the significance of oscillatory motion in relation
to the organization of cellular processes in time, the feedback of cellular signaling
processes using theoretical methods for analysing the occurrence of stable oscillations
and the arrangement of control interactions by computer simulations. In addition, we
review the models which analyse the spatio-temporal interactions within a cell using
spatio-temporal models of genetic control by including diffusion in the cytoplasm and
time delays.
Another set of modelling efforts has focussed on the Hes1 network. These studied
the modelling of transcriptional negative feedback loops and the dynamics of Hes1
oscillations considering the transcription factors and showed that reaction-diffusion
models of the hes1 system are able to produce sustained oscillations both spatially and
temporally. Also, we review some models of the STAT pathway and analyse the signal
transduction performed by the various STAT proteins.
Other studies have examined spatial effects in signalling which had been hitherto stud-
ied only in purely temporal settings: these include studies of spatial effects in the
oscillating system of p53-Mdm2 and exploring the mechanisms of DNA-damage re-
sponse to p53 and their possible relevance to apoptosis. The last set of modelling
efforts has focussed on studying the equilibrium state(s) of negative feedback systems
and investigated the existence of Hopf bifurcations for such systems
We will consider intracellular negative feedback loops specifically those involving
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transcription factors, critical contributors to cellular homeostasis and, when dysfunc-
tional, to disease processes. Most previous mathematical models examining intra-
cellular negative feedback systems have taken a simplified approach using ordinary
differential equations (ODEs) and have not considered the different spatial structures
within a cell. Such ODE models have used delays to account for the processes of
transcription, translation and transport within the cell. However, in this thesis, we con-
sider modelling the spatial interactions explicitly, using partial differential equation
(PDE) models, with the knowledge that the localisation of certain proteins is critical
for normal cellular functioning. As such, we consider mathematical models of two
such pathways - the Hes1 and p53-Mdm2 systems. Building on previous mathematical
modelling approaches, we derive systems of partial differential equations to capture
the evolution in space and time of the variables in the Hes1-Stat3 and p53- Mdm2
systems. Therefore, in Chapter 4, we begin by considering a simple example of a feed-
back inhibition system, namely that of Hes1 mRNA and Hes1 protein. We present a
mathematical model of this system, showing how our model builds on previous work
to reflect the biology in greater depth and present our computational simulation re-
sults.Theoretical studies have shown that network time delays due to the processes of
transcription and translation and protein dimerisation are key regulators of the dynam-
ics of the Hes1 feedback loop. Also, we present the P53-Mdm2 a mathematical model
of this system, showing how our model builds on previous work.
Then in Chapter 5, we expand the study of the Hes1 ODE system by consecrating
the spatio-temporal dynamic model by building the PDE model. Theoretical studies
have shown how diffusion might play a role in modulating or affecting the response.
The results are based on numerical and analytical work, some of which is detailed in
the Appendix. we conclude with a synthesis of the results. W show that the protein
Stat3 plays a central role in maintaining the segmentation clock and include the Stat3
negative feedback loop in our model. We show that the Hes1 oscillations depend on
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cyclic changes in the phosphorylation of the protein Stat3, since phosphorylated Stat3
(pStat3) increases the degradation rate of Hes1. Our extended Stat3-Hes1 model sys-
tem has been studied under different conditions such as varying the nuclear membrane
thickness, including noise in the diffusion term, considering some spatial “holes” in
the cytoplasm and the affect of convection on the model system.
In chapter 6, we consider the p53-Mdm2 system, where localisation of proteins is of
particular importance since it has implications for cancer. Again we develop a mathe-
matical model and show that network time delays due to the processes of transcription
and translation of the dynamics of the p53-Mdm2 feedback system are very important.
Alsowe studiy P53-Mdm2 model system under different conditions such as varying
the nuclear membrane thickness and including noise in the diffusion term.
Through computational simulations in chapter 5 and 6, we show that our reaction-
diffusion models are able to produce sustained oscillations both spatially and tempo-
rally, accurately reflecting experimental evidence and advancing previous models. The
simulations of our models also allow us to calculate a diffusion coefficient range for the
variables in each mRNA and protein system, as well as ranges for other key parameters
of the models, where sustained oscillations are observed.
In the final chapter of the thesis, chapter 7, we conclude with a discussion of our results
and an indication of future work in this area.
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Chapter 2
Biological Background
2.1 Introduction
In this chapter, the biology of signal transduction and the intracellular network would
be reviewed . The focus points would involve the biology of the cell cycle, the im-
portant processes of transcription and translation, the role of transcription factors (p53,
Stat3, Hes1 and the interactions among them), tumour suppressors and cancer. The
concept of negative feedback systems would be introduced.
2.2 Signal Transduction.
Effective control of cellular behaviors has serious implications in the study of bio-
logical processes and disease. The living cell can be viewed as a complex system of
interacting networks. These networks can be roughly divided into three types, signal
transduction, metabolic networks and regulatory networks.
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All organisms have the dynamic ability to coordinate constantly their activities with en-
vironmental changes. The function of communicating with the environment is called
signal transduction which is achieved through a number of pathways that receive and
process signals originating from the external environment, from other cells within
the organism and also from different regions within the cell (Istvan Petak and Kopper.
2006).
signal transduction depends on molecular circuits. These molecular circuits detect,
amplify, and integrate diverse external signals to generate responses. Signal transduc-
tion occurs when an extracellular signalling molecule binds to the cell surface where
receptor activate as sequence of the passive diffusion of the ligand through the plasma
membrane . In turn, this receptor trigger intracellular molecules creating a response
inside the cell when the ligands pass through the nuclear membrane into the nucleus,
enabling gene transcription and protein synthesis.
There are four stages in this process:
1– Membrane receptors transfer information from the environment to the cell’s inte-
rior. A few nonpolar signal molecules are able to diffuse through the cell membranes
and, hence, enter the cell, they can bind to proteins that interact directly with DNA and
modulate gene transcription. Thus, a chemical signal enters the cell and directly alters
gene expression patterns. However, most signal molecules are too large and too polar
to pass through the membrane. Thus, the molecules information must be transmitted
across the cell membrane (often referred to as the ligand) without the molecules them-
selves entering the cell. The interaction of the ligand and the receptor alters the tertiary
or quaternary structure of the receptor, including the intracellular domain. The infor-
mation embodied by the presence of the ligand, often called the primary messenger
(Berg JM 2002).
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2– Changes in the concentration of small molecules called Second messengers, that
relay information from the receptor-ligand complex. The use of second messengers
has several consequences on the cell. they can influence gene expression and other
processes after they diffuse to the nucleus, also amplified significantly in the genera-
tion of second messengers. Thus, a low concentration of signal in the environment can
yield a large intracellular signal and response (Berg JM 2002).
The regulation of gene expression is achieved through genetic regulatory systems
structured by networks of interactions between DNA, RNA, proteins and small molecules
where the majority of those molecules are proteins. It is known and understood that
the processes of transcription and translation control the level of gene expression
(Alam-Nazki and Krishnan 2012). As most genetic regulatory networks of interest
involve many components connected through interlocking positive and negative feed-
back loops (Davidson 2005; DeJong 2002). Gene regulatory networks have an impor-
tant role in every process of life, including cell differentiation, metabolism, the cell
cycle and signal transduction (Karlebach and Shamir. 2008).
3– Protein phosphorylation is a common means of information transfer. Many second
messengers elicit responses by activating protein kinases. This protein kinase and oth-
ers are the link that transduces changes in the concentrations of free second messengers
into changes in the covalent structures of proteins (Berg JM 2002).
4– The signal is terminated. Protein phosphatases are one mechanism for the termi-
nation of a signaling process. After a signaling process has been initiated and the
information has been transduced to affect other cellular processes, the signaling pro-
cesses must be terminated. Without such termination, cells lose their responsiveness
to new signals. Moreover, signaling processes that fail to be terminated properly may
lead to uncontrolled cell growth and the possibility of cancer propagation (Berg JM
7
2002).
Figure 2.1: A schematic diagram of a simplified transduction signal pathway.
2.3 Transcription and Translation
The process of creating RNA from DNA is called transcription. During transcription,
an RNA polymerase (enzyme) binds to a specific region of DNA known as a promoter
and reads the DNA sequence resulting in an antiparallel RNA strand (complementary)
which has Uracil (U) instead of Thymine (T) in the template DNA. The new strand of
RNA is called messenger RNA (mRNA). The process of transcription can be divided
into 5 stages: pre-initiation, initiation, promoter clearance, elongation and termina-
tion (Solomon et al. 2007). In eukaryotes, RNA polymerase can not recognize the
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promoter sequence directly. Instead, transcription factors (proteins) mediate the bind-
ing of RNA polymerase. So after certain transcription factors bind to the promoter,
the RNA polymerase binds to the promoter (Ouhammouch et al. 2003). All of these
events occurs in the nucleus. Mature mRNA molecules are transported to the cyto-
plasm where translation take place. Translation is the process of transforming mRNA
(produced by transcription) to produce protein by the ribosome. Once the ribosome
complex (rRNA and proteins) bind to a specific region of mRNA and start to scan the
mRNA, each nucleotide of mRNA is translated to one amino acid (Stryer and Lubert
2002) (see Figure 2.2).
Figure 2.2: A schematic diagram of transcription and translation. RNA polymerase bind
to gene promoter and begins to scan DNA sequence to generate complementary RNA-in the
nucleus. The mRNA is then transported to the cytoplasm where ribosomes binds and read
through to produce protein.
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2.4 Transcription Factors
Transcription factors (TFs) are proteins that bind to a specific DNA sequence in order
to increase or decrease mRNA production. They might function alone or in a complex
as an activator or repressor.
2.4.1 Hes1–STAT3 interactions
The Hairy and Enhancer of Split homologue 1 protein (Hes1) is a transcription fac-
tor that belongs to the family of basic helix-loop-helix (bHLH) Transcriptional sup-
pressors. Hes proteins consist of three evolutionarily conserved domains: the bHLH,
Orange, and WRPW domains (Dawson et al. 1995). In general Hes proteins suppress
transcription. The Hes1 protein plays crucial roles in controlling the proliferation of
neuronal, endocrine, T-lymphocyte progenitor cells during development and differen-
tiation (Kamakura et al. 2004).
It has been found that Hes1 can repress its own expression through direct binding to
its own promoter (i.e. a negative feedback loop (cf. Figure 2.3). Activation of Hes1
promoter leads to the production of both Hes1 mRNA and protein. The latter then
binds to a DNA sequence on the Hes1 promoter and represses Hes1 gene expression.
Due to the instability of both Hes1 mRNA and Hes1 protein, they disapper after re-
pression. Degradation of Hes1 protein relieves negative autoregluation, permitting the
next round of Hes1 expression (Kobayashi and Kageyama 2011).
Signal transducers and activators of transcription proteins (STATs) are a family of la-
tent cytoplasmic transcription factors that are activated in response to extracellular
stimuli. They were first discovered in interferon (IFN) regulated gene transcription,
specifically Stat 1 and Stat2 (Schindler et al. 992b). Today seven STAT members have
10
Figure 2.3: Schematic diagram showing that the basic Hes1 negative feedback loop is driven
externally by cyclic changes in the level of phosphorylated Stat3 (pStat3), which regulates the
degradation rate of Hes1 protein.
been identified in mammalian cells: Stat1, Stat2, Stat3, Stat4, Stat5a, Stat5b and Stat6,
ranging in size from 750-850 amino acids.
Stat3 was initially identified as the acute-phase response factor (APRF), activated by
interleukin-6, (IL-6). It was further shown that Stat3 activation occurred in the cyto-
plasm, that Stat3 phosphorylation was essential and that Stat3 binds to IL-6 response
elements of various acute-phase protein genes (e.g., the alpha2-macroglobulin, fibrino-
gen, and alpha1-acid glycoprotein genes) (Wegenka et al. 1993).
In response to growth factors, cytokines and tyrosine kinases, STATs are phosphory-
lated and form homo-dimers that translocate from the cytoplasm to the nucleus to act
as transcription activators. In normal cells, activation of STAT3 is transient, because
of proteins that act as negative regulators such as suppressors of cytokine signalling,
(SOCS), but in cancer cells STAT3 is constitutively activated. STAT3 is activated
in many human cancers and plays an important role in the activation of genes en-
coding apoptosis inhibitors, cell-cycle regulators as well as inducers of angiogenesis
(Jing and Tweardy 2005).
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Stat3, the cytoplasmic transcription factor is activated by the JAK2 ( Janus Kinase 2
gene provides instructions for making protein that promotes the growth and division
of cells ) and the phosphration process to be translocated to the nucleus and acts like
transcriptional factor in the nucleus. The main step of this process is shown in Figure
2.4. Where the inactive JAK are attached to the cytoplasmic domain cytokine recep-
tors. Then, the cytokine molecule bind to association of cytokine receptors this leading
to activate JAKs which cause phosphorylation of tyrosine residues in cytoplasmic pro-
teins of the receptors. After that, the phosphotyrosine complexes one the receptors
bind to STAT proteins this lead to phosphorylates STAT proteins. Then, it dissociate
from the receptor and the binds to one other. The STAT dimer migrates to the nucleus
then bind to the promoter region of cytokine responsive gene where it is activate gene
transcription.
It has been demonstrated that both active Notch and notch effectors (Hes1 and Hes5)
are involved in STAT3 activation. Hes1 and Hes5 proteins bind to JAK2 and STAT3,
facilitating the formation of the JAK2-STAT3 complex and STAT3 phosphorylation
activation (Kamakura et al. 2004). Research papers presented the first evidence for
crosstalk between two major signal transduction pathways, Notch-Hes and JAK-STAT3-
Hes1 and other Hes protein expression induced by the activation of Notch receptors.
Hes proteins bind to STAT3 directly inducing phosphorylation.
The Notch signaling pathway regulates cell differentiation by the intercellular commu-
nication between cells. Notch protein spans the cell membrane with part of it inside
and part outside. Ligand transmembrane proteins, binding to the extracellular domain,
induce proteolytic cleavage and release of the intracellular domain, which enters the
cell nucleus to modify gene expression (Oswald F 2001).
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Figure 2.4: Schematic diagram showing the Cytokine signaling and the activating of STAT
transcription.
In early stage, the development of the nervous system produces proneural genes such as
Ngn2 which induces the expression of Notch ligands such as Deltalike1 (DLL1) which
activate Notch signaling in neighboring cells forming the Notch domain (NICD). Then,
Notch domain move from the transmembrane region to the nucleus where it forms
NICD complex then induces expression of the basic helix-loop-helix factors Hes1 and
Hes5which repress expression of proneural genes and Notch ligands.
Microarray analysis with cultured fibroblasts identified the signal transducer, the acti-
vator of transcription (Stat3) and the suppressor of cytokine signaling (Socs3) system
as novel oscillators. Janus kinase activates Stat3 by phosphorylation, and phosphory-
lated Stat3 (Stat3-P) forms a dimer that enters the nucleus and activates expression of
target genes such as Socs3. Socs3 in turn inhibits phosphorylation of Stat3, forming a
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negative feedback loop. This negative feedback loop induces oscillations in the forma-
tion of Stat3-P and in the expression of Socs3 Fig 2.5. Especially, Stat3-P and Socs3
oscillations are coupled with Hes1 oscillation as shown in (Fig 2.5 ). Stat3-Socs3
oscillations also inhibits Hes1 oscillation. suggesting that the Stat3-Socs3 pathway
regulates oscillatory expression of Hes1 in the developing nervous system. Hes1 is re-
quired for phosphorylation of Stat3, suggesting that Hes1 oscillations and Stat3-Socs3
oscillations depend on each other (Ryoichiro and Imayoshi 2008).
Figure 2.5: Schematic diagram showing the oscillator network in neural progenitors. Hes1
expression oscillates owing to negative feedback. Formation of phosphorylated (-p) Stat3 and
expression of Socs3 also oscillate owing to negative feedback. Hes1 oscillation and Stat3-
Socs3 oscillations seem to depend on each other. Hes1 oscillation then induces Ngn2 and DII1
oscillations, which in turn activate Notch signaling in neighboring cells.
Hes1 expression is downregulated during early G1 phase, where, Hes1 is also known to
promote G1 phase progression by downregulating cyclin-dependent kinase inhibitors.
Thus, Hes1 both promotes and inhibits the cell cycle. Hes1 oscillation is required
for efficient cell proliferation and differentiation of neural progenitors. The negative
feedback loop of Hes1 was proposed by Yoshiura et al. (2007). The negative feedback
is driven by the level of phosphorylated Stat3 which in turn causes Hes1 degradation.
Using mouse fibroblasts after serum stimulation, the results of Yoshiura et al. (2007)
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showed that in the absence of STAT3 signalling, Hes1 protein is stabilized. Conversely,
when p-Stat3 formation is constitutively up-regulated, Hes1 protein is abolished. The
latter observation would support the existence of a negative feedback loop of Hes1-
STAT3 (Yoshiura et al. 2007).
2.4.2 p53–Mdm2 interactions
p53 is a tumour suppressor protein that plays a crucial role in the regulation of cell cy-
cle, apoptosis, senescence and DNA repair (Fridman and Lowe 2003; Vousden and Lu
2002). Mutant p53 genes cause approximately 50% of human cancers (Hainaut and Hollstein
2000; Feki and Irminger-Finger 2004). The progression of the cell cycle phases are
monitored at certain check points via intracellular negative signals to make sure that
a cell replicates without mistakes. If, however, an error occurs during cell replication,
the regulatory proteins are activated (O’Connell and Cimprich 2005). p53 activation
results in cell cycle arrest at G1 or G2, by stimulating some inhibitory protein such
as CKI (Lozano and Zambetti 2005). However, if DNA damage is irreparable, p53
stimulates programmed cell death (apoptosis) (Hengartner 2000).
The murine double minute oncogene expressed protein, Mdm2, is an important nega-
tive regulator of the p53 protein. It has been found that mutated p53 in many cancers
is accompanied by an over-expression of Mdm2 protein (Kussie et al. 1996). In nor-
mal conditions, the Mdm2 protein concentration is very low. There are 3 mechanisms
by which Mdm2 inhibits p53 (Vassilev et al. 2004). First, Mdm2 can bind to the p53
transactivation domain, preventing p53 to activate genes expressing proteins for DNA
repair or directing it to apoptosis. Second, Mdm2 is involved in exporting p53 from the
cell nucleus. Moreover, Mdm2 may attach to p53 as ubiquitin results upon p53 degra-
dation. After DNA damage, p53 is activated by protein kinases which phosphorylate
p53. Phosphorylation of the p53 protein prevents the Mdm2-p53 complex formation
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and p53 concentration builds up in the cell. Once the damage is repaired, phosphoryla-
tion of p53 by protein kinases stops and the Mdm2-p53 complex is reformed (Li et al.
2003).
Figure 2.6: Schematic diagram showing mechanisms of cellular stress, e.g., DNA damage,
telomere erosion, hypoxia, or oncogene expression, which can activate the p53 response path-
way. The p53-Mdm2 autoregulatory feedback loop governs the level of p53. Over-expression of
Mdm2 in human cancer, e.g., gene amplification of Mdm2, targets p53 for ubiquitin-dependent
proteolytic degradation to disable the p53 network.
2.4.3 Tumour suppressors (inhibitors)
Tumour suppressor genes encode proteins which protect cells from cancer. There are
two families of genes: the cip/kip family and INK4a/ARF. Both groups prevent the
progression of the cell cycle and the formation of tumours. For example, p21, p27
and p57 are members of the cip/kip family. They can bind to cyclin-cdk complexes
causing them to be inactivated, and hence, preventing the cell from from leaving the
G1 phase of the cell cycle. The p161NK4a protein belongs to the INK4a/ARF family.
This protein binds to CDK4 and arrests the cell in the G1 phase of the cell cycle.
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2.5 The Cell Cycle
The cell cycle is a critical regulator of the processes of cell proliferation and growth
as well as of cell division after DNA damage. The cell cycle also serves to protect the
cell from DNA damage (Schwartz and Shah 2005).
Cell division is a very important process in all living organisms. During the division
of a cell, DNA replication and cell growth also take place to ensure correct division.
These cells divide once in approximately every 24 hours and cell division properly lasts
for only about an hour. However, this duration of cell cycle can vary from organism to
organism and also from cell type to cell type.
The cell cycle is divided into two basic phases, Interphase (resting phase) is the phase
between two successive M phases where it lasts more than 95% of the duration of cell
cycle and M Phase (Mitosis phase) which is representing the phase when the actual
cell division or mitosis occurs.
The interphase is the time during which the cell is preparing for division by undergo-
ing both cell growth and DNA replication in an orderly manner. It is divided into three
further phases. First, G1 phase (Gap 1) G1 phase corresponds to the interval between
mitosis and initiation of DNA replication. During G1 phase the cell is metabolically
active and continuously grows but does not replicate its DNA. Then, S phase (Synthe-
sis) or synthesis phase marks the period during which DNA synthesis or replication
takes place. During this time the amount of DNA per cell doubles. However, there
is no increase in the chromosome number, so the number of chromosomes at S will
remains the same number of the chromosome in phase G1. Finally, G2 phase (Gap
2) During the G2 phase, proteins are synthesised in preparation for mitosis while cell
growth continues.
Some cells exhibit division because they have been lost as result of injury or cell death,
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they exit G1 phase to enter an inactive stage called quiescent stage (G0) of the cell cy-
cle. Cells in this stage remain metabolically active but no longer proliferate.
M phase is the most dramatic period of the cell cycle. The mitosis has been divided
into four stages of nuclear division. First, Prophase which is the first stage of mi-
tosis follows the S and G2 phases of interphase where new DNA molecules formed.
In the prophase, the proteinaceous components of the cell cytoplasm help to attache
the two chromatids together to form compact mitotic chromosomes. Cells at the end
of prophase, do not show golgi complexes, endoplasmic reticulum, nucleolus and the
nuclear envelope. Then, Metaphase where the complete disintegration of the nuclear
envelope marks the start of the second phase of mitosis, hence the chromosomes are
spread through the cytoplasm of the cell, and the condensation of chromosomes is com-
pleted. At this stage, chromosome is made up of two sister chromatids, which are held
together by the centromere. Hence, the metaphase is characterised by all the chromo-
somes coming to lie at the equator with one chromatid of each chromosome connected
by its kinetochore to spindle fibres from one pole and its sister chromatid connected
by its kinetochore to spindle fibres from the opposite pole. After that, Anaphase, At
the onset of phase, each chromosome arranged at the metaphase plate is splited simul-
taneously and the two daughter chromatids begin their migration towards the two op-
posite poles. Where each chromosome moves away from the equatorial plate. Finally,
Telophase, At the beginning of the final stage of mitosis, i.e., telophase, the chromo-
somes that have reached their respective poles decondense and lose their individuality.
Also, Nuclear envelope assembles around the chromosome clusters and golgi complex
and ER reform.
The timing and order of cell cycle events are monitored during cell cycle checkpoints
that occur at the G1/S phase boundary, in S phase, and during the G2/M phases. These
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checkpoints ensure that critical events in a particular phase of the cell cycle are com-
pleted before a new phase is initiated, thereby preventing the formation of genetically
abnormal cells. Cell cycle progression can be blocked at these checkpoints in response
to the status of both the intracellular and extracellular environment. Damaged cells are
eliminated through the process of apoptosis. Thus as a cell progresses through the cell
cycle, it must determine whether to complete cell division, arrest growth to repair cel-
lular damage, or undergo apoptosis if the damage is too severe to be repaired or if the
cell is incapable of repairing the DNA. It is at the checkpoints that the cell determines
which of these options is suitable (King and Cidlowski 1998).
Two types of protein are considered to be the most crucial regulatory molecules of the
cell cycle: cyclins and cyclin-dependent kinases (CDK). They control switching from
G1 to S or G2 to M. Cdk itself adds phosphate to a variety of proteins for the activation
or inactivation protein in question which in turn coordinates entry into the next phase.
In response to extracellular signals (e.g. growth factors), cyclin D activates expression
of cyclin E protein which binds to cdk2 leading the cell to move from G1 to S-phase.
Cyclin B binds to cdk1 allowing the cell to transition from G2 to M-phase. Once the
nuclear envelope breaks down, the cyclin B-cdk complex becomes inactivated and the
cell exits M-phase (Robbins et al. 2004). Targeting CDKs would recapitulate cell cy-
cle checkpoints that would necessarily limit a tumor cells ability to cycle, and this may
then facilitate the induction of apoptosis (Schwartz and Shah 2005).
During cell division a number of important cell cycle proteins are synthesized period-
ically dependent on transcription. Often the function of tumor suppressors like p53 is
to arrest cell division and to send a damaged cell into apoptosis. The group is working
on identifying transcriptional targets of p53. Thereby they discovered new signaling
pathways leading to cell cycle arrest and apoptosis (Katrien Vermeulen and Bockstaele
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2003).
This great interest in apoptosis is due to the recognition that many diseases involve
too much apoptosis or too little apoptosis. Many toxins and other cellular stresses can
also trigger apoptosis. Apoptosis is associated with a distinct set of biochemical and
physical changes involving the cytoplasm, nucleus and plasma membrane. Early in
apoptosis, the cells round up, losing contact with their neighbors, and shrink (Lawen
2003).
Apoptosis and proliferation are intimately coupled. Some cell-cycle progression is
regulated by positive and negative signals where the cell cycle regulators can influ-
ence both cell division and programmed cell death. A perfect control of cell divi-
sion is important for avoiding the development of cancer. The linkage of cell cy-
cle and apoptosis has been recognized for c-Myc, p53, pRb, Ras, PKA, PKC, Bcl-
2, NF-κB, CDK, cyclins and CKI. A direct link between cell cycle and apoptosis
may be supposed from the fact that a number of similar morphological features exist
between mitosis and apoptosis. Mitosis and apoptosis share common morphologi-
cal features such as cell shrinkage, chromatin condensation and membrane blebbing
(Katrien Vermeulen and Bockstaele 2003).
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Figure 2.7: Schematic diagram of the cell cycle. M = Mitosis, G1 = Gap 1, G2 = Gap2, S =
Synthesis.
2.5.1 Cancer
The term “cancer” is actually a broad group of diseases which may be described as
out-of-control cell growth. Cancer cells divide and grow uncontrollably. There are two
types of tumours – benign tumours and malignant tumours. In benign tumours, the
appearance of cells is often quite normal, but they divide more rapidly than normal.
Benign tumours do not invade neighbouring tissues and do not lead to metastasis (the
spread of a tumour from one organ to other non-adjacent organs.). These tumours
usually do not grow beyond 1-2 mm3 due to the lack of oxygen and nutrients.
On the other hand, malignant tumours, or cancers, display two life-threatening phe-
nomena – angiogenesis and metastasis. Angiogenesis is a process by which the tumour
cells induce blood vessels to provide them with the required nutrients needed for tu-
mour expansion. Metastasis is the process of the growth and development of secondary
tumours at distant locations in the host to the primary tumour.
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A recent seminal paper identified six key aspects of cancer, now known as “hall-
marks”, which distinguish it from normal cells/tissue involving: self-sufficiency in
growth signals, limitless replicative potential, evasion of apoptosis, tissue invasion
and metastasis, insensitivity to growth-inhibitory signals and sustained angiogenesis
(Hanahan and Weinberg 2000). The recent advancements in cancer genomics has
made it clear that different transcriptional factors such as p53, stat1 and hes1, have
unique roles in tumour development and suppression. So the possibility to use these
factors as biomarkers, tumour suppressors and gene therapy agents for cancer manage-
ment is attracting the attention of scientists and clinicians. However, these therapies
are still in their early stages of development. Hence, for the development of compre-
hensive cancer management and anticancer therapies, a better understanding of these
transcriptional factors is required. The studies on p53, stat1 and hes1 in the present
thesis aims to provide a better understanding of the relationship between cancer and
normal cells.
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Chapter 3
Mathematical Modelling of Negative
Feedback Systems
In this chapter we review some of the work done in the theoretical modelling of neg-
ative feedback systems (e.g. Hes1, p53-Mdm2) and other relevant studies. Most of
the dynamic models which represent the fundamental regulatory activity of the cell are
controlled at the level of the gene and proteins. It is important to understand the cellu-
lar organization and the dynamic activity of the molecular control processes involved
in these feedback systems and gene regulatory networks since concentration levels in
such systems are known to undergo oscillatory behaviour.
3.1 Ordinary Differential Equation Models
Perhaps the first theoretical investigation into such intracellular regulatory networks
was that of Goodwin (1965) who studied the type of periodic behaviour which can
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arise in model systems incorporating the essential control features of enzymatic regu-
latory processes and discussed the significance of oscillatory motion in relation to the
organization of cellular processes in time.
The mode of Goodwin (1965) considered the interactions between enzymes Yi and
their mRNA Xi in a negative feedback loop which lead to set of equations describing
the dynamic of this system as follows:
dXi
dt =
αi
Ai + kiYi
−bi
dYi
dt = αiXi−βi
The above system of equations i = 1,2,3... define what Goodwin (1965) termed a non-
linear biochemical oscillator. As result of this work, Goodwin (1965) reported that the
majority of enzymes in a cell are being synthesised at any one time and their synthesis
and activity are regulated by negative feedback control processes.
Goodwin (1965) also described the interactions in some intracellular processes where
one molecular species has a repressive effect on another. This feedback systems was
represented mathematically by the following system of equations:
dX1
dt =
α1
A1 + k11Y1 + k12Y2
−b1
dY1
dt = α1X1−β1
dX2
dt =
α2
A2 + k21Y1 + k22Y2
−b2
dY2
dt = α2X2−β2
The result of this study showed that the cell employs non-linear interactions between
control circuits to achieve the organization of biochemical processes in a temporal do-
main, where the behaviour of the oscillations is completely coherent and the slower
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oscillation is driven by the faster one.
In this paper, Goodwin (1965) also investigated a special class of oscillations of neg-
ative feedback control processes in the more general type of system where damping,
oscillations and limit cycle are expected. The system of equations which was studied
was the following:
dX1
dt =
α1
A1 + k1Z1
−b1X1
dY1
dt = µ1X1−β1Y1
dZ1
dt = γ1Y1−δ1Z1
These equations consider for the first time the concept of delay due to the diffusion of
molecules, the concept of “precursors” and the notion of a metabolic sequence. From
these studies the oscillatory behaviour which is expected to be a very important dy-
namic feature of cellular control processes were predicted and it was shown that the
oscillations can arise at different levels of cellular organization.
Griffith (1968a) observed that the theoretical method for analysing the circumstances
for occurrence of stable oscillations and the arrangement of control interactions was
computational simulations. He considered the Goodwin (1963, 1965) model given
schematically by G+mR = GRm where R = Repressor, combining with a gene G. The
proportion of time G is active is given by, p = 11+kxm , where the parameter m→ ∞.
Griffith used standard techniques to examine the stationary points of the system (M′ =
E ′ = 0) and their (linear) stability, and the analysis showed that were are no limit cycles.
He also studied the three variable case given by M0 = βE0, E0 = γP0, αβγP0(1+Pm0 )
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= 1. He reported that the absence of limit cycles in the two variables case should still
hold, whilst in three variable case, it would be surprising if limit cycles appeared for
very low values of m.
In a second paper, Griffith (1968b) discussed equations similar to those discussed in
Part I. He considered G+mI = GIm where I is a so-called inducer for metabolite P.
The time for which the gene G is active is given by, P = Kxm1+kxm , where K = equilibrium
constant.
Once again he is carrying out a linear stability analysis of the steady-states of the sys-
tems, the same general behaviour to the previous model was observed.
Freeman (2000) observed that the intercellular communication that regulates cell fate
during animal development must be precisely controlled to avoid dangerous errors.
Both positive and negative feedback loops play vital roles in dynamic regulation of
developmental signalling. In this paper, he analysed the temporal control of signalling,
and spatial control by feedback. He also analysed the integration of feedback events
in pattern formation. It was observed that positive and negative feedback can estab-
lish left–right asymmetry. It was reported that while positive feedback can contribute
distinct signals, negative feedback can restrict the ligand range. He also reported that
negative feedback generates stability.
Ciliberto et al. (2005) observed that oscillations can arise from a combination of pos-
itive and negative feedbacks or from a long negative feed back loop alone. In their
study they developed a mathematical model of p53 oscillations based on positive and
negative feedback in the p53 / Mdm2 network. According to the model, the system
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reacts to DNA damage by moving from a stable steady state into a region of stable
limit cycles.
They observed certain points in their model as follows:
1. p53/Mdm2 network responds to environmental stress such as gamma irradiation by
generation of pulses of p53. The oscillations produced increased with increasing stress.
2. In their model p53 level is kept low by degradation induced by Mdm2. The simu-
lated DNA damage by increasing Mdm2 degradation in nucleus.
3. They also inferred that the model can be used to formulate two experiments that
might discriminate whether oscillations are based on negative feedback look alone or
on a combination of positive and negative feedback loops.
Geva-Zatorsky et al. (2006) studied oscillations in the p53-Mdm2 system considering
negative and positive feedbacks and the mechanism of oscillations of p53-Mdm2, the
variability in p53 pulses and the potential function of p53 oscillations there. The au-
thors also studied the dynamics of the p53-Mdm2 feedback loop in individual cells.
Zhang et al. (2007) made an analytical report exploring the mechanisms of DNA-
Damage Response to p53 pulses and their possible relevance to apoptosis. They con-
structed models at protein level, with the following assumptions:
1. Transcriptional regulation is replaced by regulation corresponding to protein syn-
thesis using a Hill function given by
H(x) = x
n
Jn+xn , with Transcription Factor [TF] = x. They formulated models combining
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positive and negative feedback loops. They compared the dynamics of the following
models using
G(u,v,q,r) = 2ur
(v−u+ v.q+u.r)+
√
(v−u+ v.q+u.r)2−4u.r(r−u)
2. Heaviside function with
H(x) =

1,x > 0
0,x≤ 0
They evaluated the DNA damage and degradation rate constants using
d(DNAdamage)
dt = −krepair.H(DNAAdvantage)
kd2 = kd2(1+DNAAdvantage)
kd53 = kd53 + kd53.G[(Mdm2∗,θ ,
J1
P(53∗) ,
J2
P(53∗) ]
where, (Mdm2∗) = (MdM2nuc) and P(53∗) = [P53]
Using the above three equations, the models were organised to evaluate d(P53)dt ,
d(MdM2cyt )
dt ,
d(Mdm2nuc)
dt for the given steady state values. They generalised the model of Ciliberto et al.
(2005). They observed that in contrast to the jumping of parameter values between
steady-state and robust oscillatory state, the models proposed by them reflected that
the onset of oscillations is difficult. They observed that the model is consistent with
experimental observation and p53 phosphorylation.
Bose and Ghosh (2007) have given an overview of their studies on the p53−Mdm2
network and the associated pathways from a systems biology perspective. They discuss
a number of key predictions, related to some specific aspects of cell-cycle arrest and
28
cell death, which could be tested in experiments. They describe the mathematical mod-
els developed by them to study the p53-mediated cell cycle arrest and apoptosis. We
discuss briefly the major results obtained and point out their experimental relevance.
They considered the cell-cycle arrest, as the cell-cycle is an example of a dynamical
system in which events unfold as a function of time.
They inferred that there is a marked difference in the apoptotic response of cancer cells
with normal Mdm2 expression and Mdm2 over-expression when treated with nutlin, an
inhibitor of the p53-Mdm2 interaction. They also inferred that low levels of caspase-3
cannot bring about cell death. The amount of p21, the transcription of which is acti-
vated by p53, appears to be a crucial factor in determining the cell fate.
Zeiser et al. (2007) described a model for the Hes1 oscillator considering the transcrip-
tion factor for a single binding site described by
2X =
kd
k−d
X2
X2 +B0 =
k1
k−1
B1
with k1, k−1 being association and dissociation constants respectively. They attempted
to estimate the Hill coefficient in the switch of a Hes1 oscillator and suggested a model
of the autoregulative network. They used the Goodwin system and found sustained
oscillations.
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Puszynski et al. (2009) designed model for crosstalk between p53 and the NF-κB sys-
tem and anti-apoptotic functions of NF-κB combining their stochastic models of NF-
κB and p53 system. Their main assumption was IαBα and A20 transcription rates are
proportional to b1b1+p53pm , where pm is the amount of active nuclear p53.
3.2 Delay Differential Equation Models
Monk (2003) reported oscillatory expression of Hes1, p53, NF-κB driven by tran-
scriptional time delays. Representing Hes1 mRNA by M(t) and Hes1 protein by P(t),
he considered the system:
dM
dt = αmG[P(t)− τ]−µmM(t)
dP
dt = αpM(t)−µpP(t)
where µm, µp = rate of degradation of mRNA and Hes1, αm = basal rate of transcript
initiation and
G[P(t− τ] = 11+(P(t−τ)/P0)n , where P0 = concentration of Hes1. He also assumed the
following:
(1) The translation is non-saturating; (2) movement of Hes1 between the cytoplasm
and nucleus is neglected and (3) the delay takes a discrete value τ .
Bernard et al. (2006) studied transcriptional feedback loops and the role of Gro/TLE1
in Hes1 Oscillations, inspired by the experiments on oscillatory dynamics due to Hes1,
30
p53 and NF-KB. They studied the effects of Hes1 factor. They considered the model
of Jensen et al, Monk and Lewis which is describing the cellular concentration of Hes1
mRNA representing the cellular concentration of Hes1 protein. They also considered
an additional influencing factor namely, the Gro/TLE1 protein, activated through Hes1-
induced hyper-phosphorylation.
Momiji and Monk (2008) developed a more detailed model of the Hes1 circuit of
Monk (2003), incorporating nucleo–cytoplasmic transport. They showed that differ-
ential protein stability can increase the amplitude of Hes1 oscillations but that the
resulting expression profiles do not fully match experimental data. They considered
the delay differential equation system.
They observed that the models represent Hes1 auto-repressive feedback loop in a sim-
ple manner representing transcription, translation repression and degradation repre-
sented mathematically as if they take place in a single spatially homogeneous cellular
compartment. In order to consider additional known bio-chemical processes, they ob-
served their model of the Hes1 network incorporates the key features of Hes1 dynam-
ics, although it does not take into account the interaction of Hes1 with other biochem-
ical species. They also studied the external driving of Hes1 oscillations by STAT2
phosphorylation. They considered the model of Yoshiura et al. (2007) and extended
the model to study a three component Hes1 Model.
Nikol’skii and Vasilenko (2000) analyse the signal transduction performed by proteins
of the STAT (Signal transducer and activators of transcription) family. They observed
that the STAT Protein activator develops in two steps - first there occur phosphoryla-
tion of tyrosine, then that of serine also located in the C-terminal part of the molecule.
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They reported that unlike other short-lived transcription factors, STAT proteins have
a long half-life. It is also reported that the activated STAT molecules are inactivated
by Cytokines and growth factors that activate STAT Proteins. They concluded that the
main feature allowing proteins of the STAT family to be united into single group was
their combination of two functions - the signal and transcriptional ones. The participa-
tion of the signal transduction demonstrate once more inter connection of all cellular
process.
Bar-Or et al. (2000) reported the generation of oscillations by the p53-Mdm2 feedback
loop. Assuming that the p53 concentration obeys the kinetic equation:
d(P53)
dt = sourcep53− p53(t)Mdm2(t)degradation(t)−dP53P53(t)
where sourcep53 = synthesis rate of p53 protein and the last term reflecting Mdm2
independent mechanism for kinetics governing the Mdm2 concentration was given by
d(Mdm2)
dt = p1+ p2max
I(t)m
knm + I(t)n
−dMdm2.Mdm2(t)
where I is the Intermediary given by,
d(I)
dt = activityp53(t)− kdelayI(t)
where activity = Gsignal(t)1+C2Mdm2P53 , where the activating signal was given by,
d(signal)
dt =
−repair.signal(t).
Using the model, they reported consistency with computer simulations and observed
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that a delay in p53-dependent induction of Mdm2 is a pre-requisite for oscillatory be-
haviour and the length of delay determines period of oscillations.
Mihalas et al. (2006) studied the following system:
x
′
1(t) = 1−b1x1(t)
y
′
1(t) = x1(t)− (a1+a12y2(t− τ))y1(t)
x
′
2(t) = f (y1(t− τ))−b2x2(t)
y
′
2(t) = x2(t)− (a2+a21y1(t− τ))y2(t)
where f : R→ R, the Hill function, is given by
f (x) = x
n
a+ xn
n ∈ N+, a > 0, and all parameters are less than or equal to 1.
They studied the equilibrium state of the system and investigated the existence of Hopf
bifurcation for the system using time delay and analysed the direction of Hopf bifur-
cation by normal form theory.
Sturm and Weber (2008) discuss the use of generic methods to reduce the questions on
the existence of Hopf bifurcations in parameterized polynomial vector fields to quanti-
fier elimination problems over the reals combined with simplification techniques avail-
able in REDLOG. Using generic methods to reduce the Hopf bifurcation problem to
a quantifier, elimination available in REDLOG, one can construct most of the results
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given in the literature within less than a minute of computation time.
Shi-Wei et al. (2007) propose a statistical signal response model to describe the dif-
ferent oscillatory behaviour in a biological network motif, exploiting the non-linear
dynamics in the negative feedback loop. The delay is chosen as a bifurcation model,
the existence of Hopf bifurcation and the stability of the periodic solutions of the model
equations with the centre manifold theorem and the normal form they are discussed. It
is studied that there is a periodic solution born in a Hopf bifurcation beyond a critical
time delay and this bifurcation phenomenon may be important to elucidate the mecha-
nism of oscillatory activities in regulatory biological networks.
In this study, exploiting an auto-regulatory negative feedback loop, a statistical model
of the p53–Mdm2 negative feedback system, with the aim of describing the different
dynamical oscillatory behaviour of protein levels - both in individual and at population
cells in a self-consistent way. This is elucidated through the equations:
d(Xt)
dt = AX(t)+BX(t− τ)+F
A = (−α p(1− r0p)M−µ p−α p(1− rp)P
It is assumed that under normal conditions, the amount of p53 protein in the cell is kept
low by the genetic metric in Mdm2 and p53 itself. When cells are exposed to damaging
agents, it increases suddenly and this is followed by a cascade of events, through the
modification of the binding properties of Mdm2.
Thus the authors state that:
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(i) The p53 and Mdm2 leave their basal levels P(0) and M(0) and increase, with p53
followed by Mdm2.
(ii) After some time, due to negative feedback mechanism decreases its own along with
the level of Mdm2 and enter a stationary level (p∗,M∗).
(iii) When the signal is completely resolved, the p53-Mdm2 loop returns to the normal
case and the levels of p53 and Mdm2 to their basal values.
3.3 Partial Differential Equation Models
Building on the model of Mahaffy and Pao (1984), Busenberg and Mahaffy (1985)
considered a class of models based on the theory of Jacob and Maned (genetic repres-
sion for control of biosynthesis and pathways in cells) including both spatial diffusion
and time delays. Based on Goodwin’s assumptions, they considered the following
system:
du1(t)
dt = f (v1(t)−b1u1(t)+a1
∫
−∂ω
[u2(x1(t)−u1(t)]dSω
dv1(t)
dt = −b2v1(t)+a2
∫
−∂ω
[V2(x1(t)−V1(t)]dSω
∂u2(x, t)
∂ t = D1∆u2(x1t)−b1u2(x1t)
and
∂v2(x, t)
∂ t = D2∆v2(x1t)−b2u2(x1t)+C0u2t(x),
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where x ∈ ω , with boundary conditions,
∂u2(x, t)
∂ t = −β1[u2(x1t−u1t]
and
∂v2(x, t)
∂ t = −β
∗[v2(x1t)− v1(t)D2∆v2(x1t)−b2u2(x1t)+C0u2t(x),
∂u2(x, t)
∂ t =
∂v2(x, t)
∂ t = 0
with the constants bi = Kinetic Rates of decay, ai = rates of transfer, Di = Diffusion
Coefficients, C0 = production rate of repressor;
v1(t),u2(x) = Delayed concentrations having discrete delays or a distributed delay,
given by,
Zit =
∫ 0
−r
Zi(t +θ)dη(θ)
with
∫ 0
−r dη(θ) = 1. Also β1 and β ∗1 are Fick’s Law constants.
They obtained Differential Equation with one delays describing well mixed compart-
ment system. From the above equations, they reduced the two compartment diffusion
model to a system of delay differential equations. They established that the model re-
duces to a well mixed two compartment model when the Diffusivity tends to ∞.
Brown and Kholodenko (1999) first estimated the relative steady state gradient for a
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protein located exclusively on the cell membrane. They reported that the absolute
concentration and gradients depend on kinase activity. They concluded that if the ki-
nase and phosphatase of a protein are spatially separated in a cell, then large spatial
gradients of the phospho-protein are inevitable, which has important implications in
cell-signalling.
Rangamani and Iyengar (2006) analysed the spatio-temporal representations of dy-
namic cellular phenomena and how these models can be used to understand biolog-
ical specificity in functional response. They studied the direct interaction networks.
They observed that if the reaction is an enzyme catalysed reaction, where there is no
change in the enzyme, the rate of reaction can be formulated using Michaelis–Menten
Kinetics. They analysed chemical kinetics using ODEs and PDEs derived from the
biochemical reaction system:
A+B⇋k1k2 C
where the rate of the forward reaction = k1[A][B] and the rate of the backward reaction
= k2[C]. Net reaction rate = forward rate - backward rate.
They studied the temporal dynamics of the system by analysing the system of ODEs
and further they analysed the spatio-temporal dynamics from the system of reaction–
diffusion equations. For estimating the diffusion coefficients of the various species,
they considered the Stokes’ and the Wilke–Chang.
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Gordon et al. (2009) reported the Spatio-Temporal Modelling of P53-Mdm2 Oscilla-
tory system, investigating the spatial effects. Their spatial model accounts for both
negative feedback and transcriptional delay. Considering p53 and Mdm2 with the
six kinetic interactions namely: (1) basal p53 synthesis, (2) Mdm2 independent p53
degradation, (3) Mdm2-mediated P53 elimination, (4) basal p53-independent Mdm2
synthesis, (5) p53-induced Mdm2 synthesis and (6) Mdm2 degradation.
Sturrock et al. (2011) derived systems of partial differential equations to capture the
evolution in space and time of the variables in the Hes1 and p53-Mdm2 systems.
Through computational simulations they show that their reaction-diffusion models are
able to produce sustained oscillations both spatially and temporally, accurately reflect-
ing experimental evidence and advancing previous models. The simulations of our
models also allow us to calculate a diffusion coefficient range for the variables in each
mRNA and protein system, as well as ranges for other key parameters of the models,
where sustained oscillations are observed. Finally, by exploiting the explicitly spatial
nature of the partial differential equations,they manipulate mathematically the spatial
location of the ribosomes, thus controlling where the proteins are synthesized within
the cytoplasm. The results of their simulations predict an optimal distance outside the
nucleus where protein synthesis should take place in order to generate sustained oscil-
lations.
They inferred that the simulation results of our models have demonstrated the existence
of oscillatory dynamics in negative feedback systems both for relatively simple (Hes1)
and more complex (p53-Mdm2) pathways and have been able to focus on reactions
occurring both in the cell nucleus and in the cytoplasm. The main advantage of using
systems of PDEs to model intracellular reactions is that the PDEs enable spatial effects
to be examined explicitly.
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Cangiani and Natalini (2010) had earlier considered a spatio-temporal model for pro-
tein transport along microtubules, but not applied to negative feedback systems. This
work was extended by Sturrock et al. (2012) to account for the effect of the nuclear
membrane, active transport and cell shape on the observed oscillations.
Shymko and Glass (1974) studied spatial switching with two localised but chemically
coupled catalytic sites and analysed the dependence of stability of the steady state.
They considered the following equations:
∂ψ
∂ t +F(ψ)−D▽
2 ψ = G(ψ)∆(r)
where ψ(r,t) is the vector of concentrations. The dependence for synthesis of chemical
species was found through
fA(ψ) = b+(ψ +θ)
n
1+(ψ +θ)n
where b < 1. They showed that the qualitative dynamics of chemical systems with a
spatially heterogeneous catalyst depends in a fundamental way on the relative locations
of the catalytic sites.
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3.4 Analytical and Stochastic Models
Finally we note that recently there has been some work done in attempting to solve
models of a canonical gene regulatory network – the “self-repressing gene” (i.e. the
Hes1 system) – using analytical techniques. Several papers have adopted a stochastic
approach and constructed a so-called “Master Equation” for such systems (Hornos et al.
2005; Ramos et al. 2011; Grima et al. 2012; Miekisz and Szyman´ska 2013) governing
the probabilities fi(n, t), i = 0,1 (gene off or on) that there are n protein molecules in
the system at time t and the gene (DNA) is in the state i. Using generating function
techniques exact analytical solutions have been found for the steady-state problem and
also the time-dependent problem, providing information on the total number of protein
molecules in the system. However, we note that such models are highly theoretical and
rather abstract, treating the distinct processes of transcription and translation as one,
and ignoring all spatial effects.
3.5 Summary
Since the seminal work of Goodwin (1965) there have been many papers on gene regu-
latory networks (intracellular negative feedback systems) adopting a range of different
modelling approaches and using different mathematical techniques – ordinary differen-
tial equations, delay (ordinary) differential equations and some with partial differential
equations.
For the remainder of this thesis, we will use systems of partial differential equations
to model in an explicitly spatial way several key gene regulatory networks which have
been implicated in cancer – in particular, the Hes1 system and the p53-Mdm2 system.
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Chapter 4
A Spatio-temporal Mathematical
Model of the Hes1 and p53-Mdm2
Gene Regulatory Networks
4.1 A Spatio-Temporal Mathematical Model of the Hes1
System
4.1.1 Introduction
In this chapter we give an overview of a novel model by Sturrock et al. (2011) which
developed the original model of Monk (2003). We will subsequently extend this model
in chapter 5 and chapter 6 for Hes1 dimerization, stat3 and p53-Mdm2.
The Hes1 system is one of the most investigated feedback inhibition systems involving
41
the transcription factor Hairy Enhancer of Split 1 (Hes1) (Monk 2003). Hes1 tran-
scription factor is a protein that is encoded by the Hes1 gene and a member of the
Hes family of proteins which are basic helix-loop-helix (bHLH)-type transcriptional
repressors that possess the bHLH domain in the N-terminal region for DNA binding.
Hes1 has been shown to influence of nervous and digestive systems partially through
the Notch signalling pathway by repressing bHLH activators. Hence, it is a primary
target of Notch signalling and regulates many biological events by negatively regulat-
ing transcription of tissue-specific transcription factor (Ohsako et al. 1994).
HES1 also plays an important role in the Notch signalling pathway, (Shimojo et al.
2008). In the absence of Notch signalling, Hes1 expression is inhibited. After Notch
signals have been processed within the cell, the plasma membrane releases the in-
tracellular domain of Notch, which moves to the nucleus where it associates with
RBPJ forming a complex that lead to activates Hes1 expression. Notch signalling
activates Hes1 expression where HES1 has been shown to target Notch ligands such
Dll1, Jagged1 (Jag1), and Neurogenin-2 (Ngn2) (Kageyama 1999).
Also, Hes1 can repress its own production by directly binding to N-box target se-
quences in its own promoter and represses the transcription of hes1 mRNA, thus form-
ing a negative feedback loop, which produces oscillations in Hes1 gene expression.
The interaction of the Hes1 system is similar to the generic example of a negative
feedback loop with variable X and Y (see Figure 4.1). An increase in X causes Y to
increase, which in turn results in the inhibition of X. After X begins to decrease Y
levels will diminish, and this allows X to increase again. The repetition of this process
produces oscillations in X and Y. Figure 4.2 shows that Hes1 follows the same process
to produce oscillations, where Hes1 protein is produced by Hes1mRNA and then goes
on to inhibit its own mRNA and so forth, with the result that the system oscillates with
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period of around 120 minutes. Hes1 oscillations are important for the maintenance
and proliferation of neural stem cells under the control of Notch signalling (Baek et al.
2006).
Figure 4.1: A generic negative feedback loop.
4.2 A Mathematical Model of the Hes1 System
Mathematical modelling of intracellular regulatory systems has developed since it be-
gan in 1965 with the work of Goodwin (1965). Monk (2003) was the first to consider
biological data to develop a mathematical model of the Hes1 system. The basic re-
action kinetics for this system modelled using ordinary differential equations are as
follows:
d[M]
dt =
αM
1+( [P]p̂ )h
−µM[M] (4.1)
d[P]
dt = αP[M]−µP[P] (4.2)
where [M] and [P] are the concentrations of Hes1 mRNA and Hes1 protein, respec-
tively.
The first term on the right hand side of Eq.(4.1) is a Hill function which decreases as
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the protein concentration increases, modelling repression by the Hes1 protein. The
parameter αM is the rate of transcript initiation in the absence of Hes1 protein and p̂ is
the concentration of Hes1 and h is a Hill coefficient. The second term represents the
natural degradation of the Hes1 mRNA with parameter µM .
The first term on the right hand side of Equation (4.2) is the Hes1 protein production
term from translation of Hes1 mRNA with parameter αP and the second term repre-
sents Hes1 protein degradation with parameter µP.
A standard mathematical analysis shows that two-component models with negative
feedback cannot have stable self-sustained oscillations (Bernard et al. 2006). In order
to model the intracellular processes, Monk (2003) introduced a time-delay to equations
(4.1), (4.2) to account for the processes of transcription and translation, and obtained
sustained oscillations.
The two-compartment model for Hes1-mRNA self-repression with time-delay can be
written as a system of delay differential equations (DDEs):
d[M]
dt =
αM
1+( [P(t−τM)]p̂ )h
−µM [M] (4.3)
d[P]
dt = αP[M(t− τP)]−µP[P] (4.4)
where τM and τP are the transcriptional and translational delays, respectively.
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Figure 4.2: A schematic diagram of the Hes1 gene regulatory network. hes1 mRNA is tran-
scribed in the nucleus. It is then exported to the cytoplasm where translation into Hes1 protein
occurs. hes1 mRNA is then inhibited in the nucleus by its own protein. This is one of the
simplest examples of a negative feedback loop.
A Time Delay Model
We here turn our attention to time delay in the transcription and translation processes.
Many physiological systems which operate by feedback mechanisms have time de-
lays occurring during the main process of receiving the effect and the physiological
response. Therefore a time delay is a natural occurrence due to the finite transmission
speed of matter, energy and information (Yutaka and Shinji 2011).
A time delay exists in the Hes1 system if any of the processes inside the cell take longer
than others. For example, a time delay could exist in the mRNA transcription or in the
protein translation or it could be in both.
We rewrite the system of equations (4.1), (4.2) considering the time delay first caused
by the delay in mRNA transcription, then by the delay in protein degradation and
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finally by both interaction, transcription and production. Then we will study the system
numerically using the parameter values in Table 1 to show the effect of the time delay
on the oscillations.
Table 4.1: List of parameter values
Parameters Values
αM 1
αP 1
µM 0.1
µP 1
τM 20
τP 20
h 5
p̂ 1
For a delay caused in the protein production by the mRNA, in the cytoplasm which
may coursed by the interaction of the Hes1 with other intracellular proses such as the
activation of JAK-STAT interaction or by the activating Notch signalling.
To study the delay in protein production, equations (4.1), (4.2) become:
d[M]
dt =
αM
1+( [P]p̂ )h
−µM [M] (4.5)
d[P]
dt = αP[M(t− τP)]−µP[P] (4.6)
If the delay was in the mRNA transcription then we have the following equations:
d[M]
dt =
αM
1+( [P(t−τM)]p̂ )h
−µM [M] (4.7)
d[P]
dt = αP[M]−µP[P] (4.8)
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Figure 4.3: Plot of Hes1 mRNA (red) and Hes1 protein (blue) concentrations against time with
delay parameter τ = 20. Computational simulation of the model with delay in Hes1 protein
production, system of equations (4.5),(4.6). Oscillations are observed in the concentrations of
both hes1 mRNA and HES1 protein.
Finally, if the delay was a result of both processes of mRNA transcription and protein
production, the equations are as follows:
d[M]
dt =
αM
1+( [P(t−τM)]p̂ )h
−µM [M] (4.9)
d[P]
dt = αP[M(t− τP)]−µP[P] (4.10)
We solve the systems of equations numerically using the parameter values in Table 1
and, as expected, we obtain oscillations in both hes1 mRNA and Hes1 protein levels.
Figures 4.3, 4.4 and 4.5 show the oscillation of the concentrations of Hes1 mRNA and
Hes1 protein vary over time. By comparing Figures 4.3, 4.4 and 4.5, we see that os-
cillatory dynamics are sustained steady and the delay does not caused big different on
the oscillation. However, mRNA transcription delay has slightly delay on the protein
production in Fig 4.4 comparing to the delay caused by the protein production itself
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Figure 4.4: Plot of Hes1 mRNA (red) and Hes1 protein (blue) concentrations against time
with delay parameter τ = 20. Computational simulation of the model with delay in hes1 mRNA
transcription, system of equations(4.7),(4.8). Oscillations are observed in the concentrations
of both hes1 mRNA and HES1 protein.
in Fig 4.3, while Fig 4.5 shows the oscillation takes more time for the mRNA and the
protein to shift between the cytoplasm and the nucleus.
4.3 The Hes1 Spatio-temporal Mathematical Model
We now extend the previous models and consider spatial interactions within the cell as
shown in Figure 4.6. We consider the nucleus and cytoplasm as two spatial compart-
ments separated by the nuclear membrane (in all subsequent analysis and models, zero
flux boundary conditions are imposed on all species at the cell membrane). Also, we
couple the reaction kinetics from ODE model (4.1), (4.2) with diffusion to model the
protein and mRNA transport within the cell.
Hes1 transcription occurs in the nucleus to produce hes1 mRNA which then transfers
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Figure 4.5: Plot of Hes1 mRNA (red) and Hes1 protein (blue) concentrations against time
with delay parameter τ = 20. Computational simulation of the model with delay in both hes1
mRNA transcription and Hes1 protein production, system of equations(4.9,4.10). Oscillations
are observed in the concentrations of both hes1 mRNA and HES1 protein.
to the cytoplasm where Hes1 protein synthesis occurs. We assume that the mechanism
governing the spatial movement of the mRNA and the protein between the nucleus and
the cytoplasm is diffusion.
The system of equations of the spatio-temporal evolution of hes1 mRNA and Hes1
protein is now:
∂ [Mn]
∂ t = DMn∇
2[Mn]+
αM
1+( [Pn]p̂ )h
−µM[Mn], (4.11)
∂ [Mc]
∂ t = DMc∇
2[Mc]−µM[Mc], (4.12)
∂ [Pc]
∂ t = DPc∇
2[Pc]+αP[Mc]−µP[Pc], (4.13)
∂ [Pn]
∂ t = DPn∇
2[Pn]−µP[Pn], (4.14)
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where [Mn] ,[Mc], [Pn] and [Pc] are the concentration of the nuclear and the cytoplasmic
hes1 mRNA and the nuclear and the cytoplasmic Hes1 protein respectively. [Di] de-
note the diffusion coefficients for each species.
Figure 4.6: Schematic diagram showing how the spatial interactions between hes1 mRNA
and Hes1 protein are modelled. hes1 mRNA is produced in the nucleus (transcription), then
exported across the nuclear membrane into the cytoplasm where it is translated into protein,
i.e., transcription occurs exclusively in the nucleus and translation/synthesis occurs exclusively
in the cytoplasm. Hes1 protein is then imported back across the nuclear membrane to the
nucleus where it inhibits the production of its own mRNA, i.e., a negative feedback loop exists.
Continuity of flux boundary conditions across the nuclear membrane allow import and
export of hes1 mRNA and Hes1 protein, while zero flux boundary conditions at the
outer cell membrane ensure that all molecules remain within the cell.
50
DMn
∂ [Mn]
∂n = DMc
∂ [Mc]
∂n and [Mn] = [Mc] at the nuclearmembrane (4.15)
DPn
∂ [Pn]
∂n = DPc
∂ [Pc]
∂n and [Pn] = [Pc] at the nuclearmembrane (4.16)
∂ [Mc]
∂n = 0, at the cell membrane (4.17)
∂ [Pc]
∂n = 0, at the cell membrane (4.18)
Equations (4.11)–(4.14) represent a system of reaction-diffusion equations modelling
the spatio-temporal evolution of the Hes1 system. The same reaction kinetics from
the ODE model (4.1), (4.2) are retained but are now also coupled with diffusion to
model explicitly protein and mRNA transport within a cell, i.e., molecules move from
the nucleus to the cytoplasm and cytoplasm to nucleus across the nuclear membrane.
The PDE system reflects the reality that mRNA is transcribed from DNA exclusively
in the nucleus and that protein is translated from mRNA exclusively in the cytoplasm,
i.e., there are production terms only for [Mn] (in Eq. (4.11)) and [Pc] (in Eq. (4.13)).
Finally, we make the assumption that the translation of proteins from mRNA in the
cytoplasm occurs some distance away from the nucleus and outside the endoplasmic
reticulum (ER), since proteins produced in the ER are mainly either exported to the
exterior of the cell or transported to other membrane structures such as the Golgi ap-
paratus, lysosomes and endosomes(Alberts et al. 1994), (?).
In order to model this, we modify Equation (4.13) as follows:
∂ [Pc]
∂ t = DPc∇
2[Pc]+H1(x,y)αP[Mc]−µP[Pc] (4.19)
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where H1(x,y) is a Heaviside function localising the protein production whose specific
form will be given after the nondimensionalisation of the system. The H1(x,y) func-
tion takes the is value zero (0) in a region just outside the nucleus, meaning there is no
protein synthesis in this ER region. In a region further away from the nucleus (outside
the ER) the function takes the value one (1), in the region of the cytoplasm where we
assume the translation of protein occurs.
We nondimensionalise Equations (4.11), (4.12), (4.14) and (4.19) with scaling vari-
ables as follows (see Appendix A):
[Mn] =
[Mn]
m0
, [Mc] =
[Mc]
m0
, [Pn] =
[Pn]
p0
, [Pc] =
[Pc]
p0
t =
t
τ
, X =
x
L
, Y =
y
L
(4.20)
where [m0] ,[p0] are reference concentration, τ is reference time, and L is a reference
length. Using this scaling Equations (4.11), (4.12), (4.14) and (4.19) become:
∂ [Mn]
∂ t = D
∗
Mn∇
2[Mn]+
α∗M
1+(p∗[Pn])h
−µ∗M[Mn] (4.21)
∂ [Mc]
∂ t = D
∗
Mc∇
2[Mc]−µ∗M[Mc] (4.22)
∂ [Pc]
∂ t = DPc∇
2[Pc]+H1(x,y)αP[Mc]−µP[Pc] (4.23)
∂ [Pn]
∂ t = D
∗
Pn∇
2[Pn]−µ∗P[Pn] (4.24)
where
52
D∗Mn =
τDMn
L2
, D∗Mc =
τDMc
L2
, D∗Pn =
τDPn
L2
, D∗Pc =
τDPc
L2
α∗M =
ταM
m0
, α∗P =
ταP
p0
µ∗M = τµM , µ∗P = τµP , p∗ =
p0
p̂
(4.25)
and
H1(x,y) =
 0, if
x2
2 + y
2 ≤ 0.25,
1, if x22 + y
2 > 0.25.
We apply zero initial conditions, zero-flux boundary condition at the cell membrane
and flux continuity boundary conditions across the nucleus membrane:
[Mn] = [Mc] = [Pn] = [Pc] = 0, at t = 0 (4.26)
D∗Mn
∂ [Mn]
∂n = D
∗
Mc
∂ [Mc]
∂n and [Mn] = [Mc] at the nuclearmembrane (4.27)
D∗Pn
∂ [Pn]
∂n = D
∗
Pc
∂ [Pc]
∂n and [Pn] = [Pc] at the nuclearmembrane (4.28)
∂ [Mc]
∂n = 0, at the cell membrane (4.29)
∂ [Pc]
∂n = 0, at the cell membrane (4.30)
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Due to a lack of experimental data, we take reference concentrations to be [m0]=0.05µM
and [p0]=1µM. Figures 4.7, 4.8 show the computational simulation results of Equa-
tions (4.21)-(4.24), where oscillations in concentrations are observed with a period of
oscillation of approximately 200 time units. Knowing that the period of oscillation of
Hes1 is approximately 2hours (Hirata et al. 2003) we can estimate the reference time
τ as follows: 200τ =2 h which means τ= 36 s.
To obtain the value of the variable L we used 2-dimensional cell domain with length of
30µM to represents both the nucleus and cytoplasm where the nucleus has a major axis
of length 0.8 units and minor axis of length 0.5 units and the cytoplasm has a major
axis of length 3 units and a minor axis of length 2 units. Hence, the non-dimensional
cell width is equal to 3 L = 30µM so, the reference length L=10µM.
Parameter Estimation
The following parameter values were used in our simulations of the non-dimensional
Hes1 system:
D∗Mn = D
∗
Mc = D
∗
Pn = D
∗
Pc = 7.5×10
−4
α∗M = 1 , α∗P = 2 , h = 5 , p∗ = 1 , µ∗M = µ∗P = 0.03 (4.31)
From (4.19) and (4.25) we calculate the dimensional parameter values as follows:
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DMn =
L2D∗Mn
τ
= 2.08×10−11cm2s−1
so : DMn = DMc = DPn = DPc = 2.08×10−11cm2s−1
αM = 1.39×10−9Ms−1, αP = 1.11s−1
µM = µP = 8.33×10−4s−1, h = 5, p0 = 1×10−6M
We carried out a number of simulations on the Hes1 system (4.21)-(4.24) to obtain the
range of diffusion coefficients for which we observe oscillations (all other parameters
remain unchanged). The system exhibits oscillations when the mRNA and the protein
diffusion coefficients have a value in the range 1.67× 10−11 to 9.72× 10−11cm2s−1.
We have also calculated a range of mRNA degradation rates: 1.67× 10−4to 1.17×
10−3s−1, protein degradation rates 1.94×10−4 to 1.06×10−3s−1 and Hill coefficients
h≥ 4 for which the system exhibits oscillations.
4.3.1 Computational Simulation Results
We solve the system (4.21)-(4.24) numerically using COMSOL/FEMLAB package
which uses the finite element technique. Triangular basis elements and Lagrange
quadratic basis functions along with a backward Euler time-stepping method for in-
tegrating the equations were used in all simulations.
Figure 4.7 shows the total concentrations of hes1 mRNA and Hes1 protein over time
in the nuclear compartment, while Figure 4.8 shows the total concentrations in the cy-
toplasm.
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Figure 4.7: Plot of the concentrations of hes1 mRNA (red) and Hes1 protein (blue) in the
nucleus over time. The period of oscillations is approximately 120 min
Figure 4.8: Plot of the concentrations of hes1 mRNA (red) and Hes1 protein (blue) in the
cytoplasm over time. The period of oscillations is approximately 120 min
The plots presented in Figures 4.9 and 4.10 show how the hes1 mRNA and Hes1 pro-
tein concentrations vary spatially as well as temporally within the cell. The mRNA is
produced inside the nucleus and by t = 60 min has started to cross the nuclear mem-
brane to enter the cytoplasm (Figure 4.9). In the cytoplasm the mRNA is translated
into protein, which then diffuses back into the nucleus and represses the production of
its own mRNA t = 120min. The mRNA concentration has clearly depleted by t = 120
min, reflecting the period of the temporal oscillation seen in Figures 4.7, 4.8. As can
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Figure 4.9: Plots showing the spatio-temporal evolution of hes1 mRNA concentration within
the cell from times t=0 to 480 min at 60 min intervals. The concentration oscillates in both
time and space. Parameter values as per (25).
be seen from Figure 4.10, there is a delay in the rise of protein concentration after
t = 0 as it takes time for the mRNA to be produced and exported to the cytoplasm. By
t = 60 min the protein levels have clearly risen in the cytoplasm and have reached the
nucleus. At t = 120 min the protein concentration has decreased significantly, due to
the inhibition of mRNA transcription by the protein.
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Figure 4.10: Plots showing the spatio-temporal evolution of Hes1 protein concentration within
the cell from times t=0 to 480 min. The concentration oscillates in both time and space. Pa-
rameter values as per (25).
4.4 A Spatio-Temporal Mathematical Model of the P53-
Mdm2 System
4.4.1 Introduction
p53 is known as protein 53 or tumour protein 53 (on account of its molecular weight).
The p53 gene was identified in 1979 by Arnold Levine, David Lane and Lloyd Old, but
in 1989 it found its role in the cell as a tumour suppressor gene (Lane and Crawford
1979). It plays an important role in multicellular organisms where it is a transcription
factor that regulates the cell cycle, functions as a tumour suppressor and is involved in
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preventing cancer. Mutations that inactivate p53 function have been detected in more
than 50% of human cancers (Bennett et al. 1999).
In normal unstressed cells the concentration level and activity of p53 are low, whereas
the concentration of p53 increases and is negatively regulated in response to stress sig-
nals such as DNA damage due to Mdm2 induced degradation.
The regulation of the p53 protein by mdm2 goes through four successive phases of the
standard eukaryotic cell cycle including, mitosis (M phase), gap1 (G1 phase), synthesis
(S phase) and gap2 (G2 phase). There are several nuclear proteins involved in the regu-
lation of DNA replication during the cell growth (Alberts et al. 1994). The p53 tumour
suppressor protein is one of the most important nuclear proteins involved in growth
arrest, apoptosis and DNA repair (Melino et al. 2003). In normal unstressed cells, the
levels of p53 protein are sustained at low levels via interaction with other protein such
as MDM2 (murine double minute 2). Once the levels of p53 protein increases, for
example after DNA damage, it acts as a transcription factor, inducing the expression
of several genes such as Bax (apoptosis inducer), p21 WAF1, which induces growth
arrest (Freedman and Levine 1998). Upon several types of stresses, the p53 pathway
has been divided into five stages, the stress signals which activate p53 pathway, detec-
tion and interpretation of the upstream signals by the upstream mediators, interaction
of p53 with several proteins which lead to its stability, transcriptional activation and
protein-protein interactions and the final outcome, growth arrest , apoptosis or DNA
repair (Levine et al. 2006). As mentioned previously, in normal conditions, the level
of p53 protein is down-regulated through its interaction with mdm2 protein which en-
hances p53 degradation in the cytoplasm or via a p53-mdm2 complex in the nucleus,
preventing p53 to activate transcription (Thut et al. 1997). Specifically, p53 protein
utilizes its NH2-terminal domain to activate its own transcription. The mdm2 binds to
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this region blocking this ability (Lu and Levine 1995). The mdm2 protein has the abil-
ity to shuttle between the nucleus and cytoplasm due to the NES sequence (Roth et al.
1998). Its activity is essential for shuttling p53 to the cytoplasm for degradation by
cytoplasmic proteasomes. Figure 4.11 summarizes regulation of the p53 by the mdm2
in normal cells. The ability of mdm2 protein to shuttle p53 from the nucleus to the
cytoplasm was proposed by Freedman and Levin, (1998). In a later model, mdm2,
p53,CRM1,and RanGTP form a ternary complex in the nucleus Figure 4.12. This trig-
gers transportation of the complex through the nuclear pore to the cytoplasm where
p53 protein is degraded while the mdm2 protein is returned to the nucleus.
Following DNA damage, p53 protein is stabilized and activated as a transcription fac-
tor that induces expression of several genes. It has been demonstrated that after DNA
damage, the ability of mdm2 to down-regulate p53 either via degradation or by form-
ing a complex to prevent transcription were lost although high levels of mdm2 were
observed (Landers et al. 1997).
The tumour suppressor protein p53 has been observed in a wide variety of human
cancers. Loss of p53 gene from chromosome 17 was reported in several cancers
(Vogelstein et al. 1988). Another study showed that the p53 gene contains point mu-
tations in the lung cancer (Takahashi et al. 1989). The inactivation of p53 could be
caused in several ways: mutation occurrence found in 50% of human cancers. Some
viruses such as SV40, HPV or adenoviruses encode proteins that inhibit p53 protein.
In both cases of inflammatory breast cancer and neuroblastoma, the accumulation of
p53 protein in the cytoplasm was reported. The accumulation of mdm2 protein in some
types of cancers was observed.
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Figure 4.11: A model of the regulation of the p53 protein by the mdm2 protein. (A) To pre-
vent p53 transcription in the nucleus, mdm2 binds to p53 protein. utilizing RanGTP-dependent
pathway, mdm2 shuttle p53 from nucleus to cytoplasm for degradation by proteasomes. (B)
After DNA damage, mdm2 becomes inactive via blocking p53-mdm2 complex formation, lower
mdm2 levels and blocking mdm2 nuclear transportation. (C) p53 remains active as transcrip-
tion factor and tumour suppression in the nucleus in order to cause growth arrest or apoptosis.
(D) After the DNA is repaired mdm2 become active again, practicing its function as autoregu-
latory protein controlling p53 in the nucleus (Adapted from Freedman and Levine, 1999).
Figure 4.12: A model for the transportation of p53 from the nucleus to the cytoplasm by mdm2.
It is believed that mdm2, p53, CRM1 and RanGTP form complex that trigger transportation
of p53 to the cytoplasm. The mdm2 then is separated from p53 and is returned the nucleus
(Adapted from Freedman and Levine, 1998)
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4.5 Mathematical Modelling of the p53-Mdm2 System
Mdm2 functionally interacts with many proteins involved in the control of cell prolif-
eration and survival. Mdm2 acts as a direct negative regulation of p53. This occurs
through two main mechanisms: first, transcriptional activation of p53; second, target-
ing p53 for modification and degradation (Manfredi 2010).
The basic interaction between p53 and Mdm2 creates a negative feedback which is
shown in the schematic digram in Figure 4.13.
Figure 4.13: A schematic representation of the p53-Mdm2 model.
We begin by looking at the fundamental reaction kinetics of the system. Denoting the
concentrations of p53, Mdm2 and Mdm2 mRNA by [p], [M] and [Mm], respectively,
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the ODE system below is formulated to capture the interactions depicted in Figure
4.13:
d[P]
dt = β − (µ +ν(
[M]h1
M̂h1 +[M]h1
))[P] (4.32)
d[Mm]
dt = α +η(
[P]h2
P̂h2 +[P]h2
)−φ [Mm] (4.33)
d[M]
dt = γ[Mm]−ρ [M] (4.34)
where [P], [Mm] and [M] are the concentration of p53, Mdm2 mRNA and Mdm2 pro-
tein, respectively.
The first ODE equation (4.32) for p53 has β as a production term of p53 followed by
a natural degradation term of rate µ , and ν a degradation term of Mdm2. The second
ODE (4.33) for Mdm2 mRNA, has a production rate α , followed by η a production
term of p53, and finally φ degradation rate. The final ODE (4.34) is for the Mdm2
protein, which has γ a production rate of Mdm2 mRNA and ρ a degradation rate. M̂
and p̂ are activation thresholds, and h1 and h2 are Hill coefficients.
Table 4.2: Parameters value
Parameters Values Parameters Values
β 10 µ 0.00025
ν 64 α 0.00235
η 40 φ 0.8
γ 01 ρ 3
A 0.05 B 1.066
h1 1 h2 50
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We are going the study the system (4.32), (4.33) and (4.34) numerically using the pa-
rameter values in Table (4.2) to show the oscillations of the system.
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Figure 4.14: Plot of p53 (red), Mdm2 mRNA (blue) and Mdm2 protein (green) concentrations
against time with no delay. Computational simulation of the model with parameter values in
Table (4.2).
Figure 4.14 shows the simulation of the p53-Mdm2 model without a time delay.
4.5.1 A Model with Time Delay
A time delay exists in the system if any of the processes inside the cell take longer
than others. For example, a time delay could exist in the protein transcription or in the
mRNA translation or it could be in both. As before with the Hes1 system, Monk (2003)
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added a delay to account for transcript elongation, splicing, processing and export.
Following Monk (2003), we rewrite the equation system (4.32), (4.33) and (4.34) con-
sidering the time delay firstly caused by the delay in mRNA transcription, then by the
delay in protein degradation and finally by both of the delays. Then we are going the
study the system numerically using the parameter values in Table 4.2 to show the effect
of the time delay on the system.
If the delay is associated with p53, equations (4.11), (4.12) and (4.13) become:
d[P]
dt = β − (µ +ν(
[M]h1
M̂h1 +[M]h1
))[P] (4.35)
d[Mm]
dt = α +η(
[P(t− τ)]h2
P̂h2 +[P(t− τ)]h2
)−φ [Mm] (4.36)
d[M]
∂dt = γ[Mm]−ρ [M] (4.37)
If the delay was in the Mdm2 mRNA transcription then we would have the following
equations:
d[P]
dt = β − (µ +ν(
[M]h1
M̂h1 +[M]h1
))[P] (4.38)
d[Mm]
dt = α +η(
[P]h2
P̂h2 +[P]h2
)−φ [Mm] (4.39)
d[M]
∂dt = γ[Mm(t− τ)]−ρ [M] (4.40)
If the delay was associated with the Mdm2 protein then we would have the following
equations:
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Figure 4.15: Plot of p53 (red), Mdm2 mRNA (blue) and Mdm2 protein (green) concentrations
against time with tau = 5. Computational simulation of the model with delay in p53 protein
degradation. System of equations (4.35), (4.36) and (4.37) with parameters values in Table
(4.2).
d[P]
dt = β − (µ +ν(
[M(t− τ)]h1
M̂h1 +[M(t− τ)]h1
))[P] (4.41)
d[Mm]
dt = α +η(
[P]h2
P̂h2 +[P]h2
)−φ [Mm] (4.42)
d[M]
∂dt = γ[Mm]−ρ [M] (4.43)
We solve the systems of equations numerically using the parameter values in Table 4.2.
As expected, we obtain oscillations from the negative feedback system.
It is clear that the concentrations of the variables reach higher levels compared with
the result of the oscillation in Fig 4.14. Figure 4.15 shows the result of the equations
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Figure 4.16: Plot of p53 (red), Mdm2 mRNA (blue) and Mdm2 protein (green) concentrations
against time with delay τ = 5. Computational simulation of the model with delay in Mdm2
mRNA degradation. System of equations (4.38), (4.39) and (4.40) with parameters value in
Table (4.2).
(4.35), (4.36) and (4.37) when we consider the time delay through the p53 degradation
process. Mdm2 mRNA takes more time to diffuse between the two domains (nucleus,
cytoplasm) thus its concentration is higher than the concentration of the other compo-
nents.
Figure 4.16 shows the result of the equations (4.38), (4.39) and (4.40) when we con-
sider the time delay through the Mdm2 mRNA degradation process. p53 takes more
time to diffuse between the two domains thus its concentration is higher than the con-
centration of the other components whereas the Mdm2 mRNA diffuses faster.
In Figure 4.17, the result of the equations (4.41), (4.42) and (4.43) simulation when we
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Figure 4.17: Plot of p53 (red), Mdm2 mRNA (blue) and Mdm2 protein (green) concentrations
against time with delay τ = 5. Computational simulation of the model with delay in Mdm2
protein degradation System of equations (4.41), (4.42) and (4.43) with parameter values in
Table (4.2).
consider the time delay through the Mdm2 protein degradation process are given. It
shows the Mdm2 protein diffusion is following the p53 diffusion while it is not in other
figure. So adding the time delay has quickened the Mdm2 protein shuttle between the
nucleus and the cytoplasm.
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Chapter 5
A Spatio-temporal Mathematical
Model of the Hes1 System
Incorporating Dimerization
The chapter can be broadly organized into three parts. In the first part of this chapter
we extend the ODE model analysed in (Momiji and Monk 2008) by building the PDE
model for Hes1 dimeraization system and run the simulation for the model. Then, in
the second part, we present the ODE model of Stat3 and extend the model by consid-
ering diffusion (i.e. a PDE model) and run the simulation of the model. Finally we
analysed the impact of the Stat3 PDE model on the Hes1 PDE model in the first part
and examined the effects on the model such as varying nuclear membrane thickness,
adding diffusion noise, and adding convection (modelling molecular transport along
microtubules) to the model.
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5.1 Introduction
We start this chapter by developing the previous model to include the effect of Hes1
dimeraization. In order to do this, we first consider the delay ODE model of Momiji
and Monk (2008).
Oscillations in molecular species concentration levels are the sign of complex genetic
regulatory network involving a negative feedback loop. it plays an important role in
wide rang of cellular phenomena. Many of the biological processes involve transcrip-
tional oscillations which depends on a segmentation clock to organise transcriptional
oscillations in complex networks of interactions (Momiji and Monk 2008). The oscil-
latory expression of Hes1 has been shown to be involved in the segmentation clock.
The model in Equations (4.1) and (4.2) in chapter 4 encodes the Hes1 feedback loop in
simple manner, representing only transcription, translation and degradation. However,
there are several other important biochemical processes involved in the Hes1 feedback
loop. Momiji and Monk (2008) used experimental biological data to develop a more
detailed Hes1 model to generate protein oscillation. Momiji and Monk (2008) consider
seven biochemical prosses such as transcription, translation, repression, degradation,
protein shuttling and protein dimerisation.
Figure 5.1 represents schematically the mass action kinetics for the main processes in-
volved in the more complex Hes1 feedback circuit as it is presented in Momiji and Monk
(2008).
We sumraize the intracelullar processes involved in the Hes1 feedback loop.
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Figure 5.1: Schematic diagram illustrating the more detailed biochemical processes associ-
ated with the Hes1 feedback network.
(1) Transcription: the hes1 gene is transcribed in the nucleus to produce nascent
hes1 mRNA, which is then spliced and processes prior to export from the nu-
cleus. This linear elongation process involves a time delay (Mahaffy and Pao
1984).
(2) Nuclear export of mRNA: mature mRNA is transported out of the nucleus to the
cytoplasm.
(3) Translation: hes1 mRNA is translated to produce monomeric Hes1 protein molecules.
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Table 5.1: List of parameters values used the model of Momiji and Monk (2008)
Parameters Values
µ1 0.03
µ2 0.03
µ3 0.3
µ4 0.03
µ5 0.03
k1 10
k2 1
k3 10
k4 0.01
k5 0.001
k6 10
k7 0
τ1 14
τ2 2
n 5
p0 1250
(4) Protein dimerisation: two Hes1 protein monomers can bind to form a Hes1 ho-
modimer.
(5) Nucleo-cytoplasmic shuttling: Hes1 dimers can shuttle between the cytoplasm
and the nucleus.
(6) Transcriptional repression: Hes1 dimers bind to specific sequences in the pro-
moter region of the hes1 gene, resulting in a reduction in the rate of hes1 tran-
scription (Takebayashi et al. 1994).
(7) Degradation: both hes1 mRNA and Hes1 protein are unstable, having half lives
of around 20–25 min (Hirata et al. 2003).
Momiji and Monk (2008) build a simple model using the mass action kinetics to rep-
resent the circuit mathematically by a five-variable system as follows:
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d[y1]
dt = −(µ1 + k2)[y1]+ k1[
1
1+( pp0 )
n
][[y5](t− τ1)] (5.1)
d[y2]
dt = −µ2[y2]+ k2[y1] (5.2)
d[y3]
dt = −µ3[y3]+ k3[y2](t− τ2)−2k4[y3]
2 +2k5[y4] (5.3)
d[y4]
dt = −(µ4 + k5 + k6)[y4]+ k4[y3]
2 + k7[y5] (5.4)
d[y5]
dt = −(µ5 + k7)[y5]+ k6[y4] (5.5)
where y1-y5 represent the concentrations of mRNA in the nucleus, mRNA in the cyto-
plasm, Hes1 monomer in the cytoplasm, Hes1 dimer in the cytoplasm, and Hes1 dimer
in the nucleus, respectively. µ1-µ5 are the linear degradation rates of the corresponding
components; k1-k7 are rates of mRNA production, mRNA export, protein production,
dimerisation, dimer dissociation, protein import, and protein export, respectively; τ1
and τ2 are the time delays in transcription and translation.
Then, Momiji and Monk (2008) solve the five equation system using the parameter
listed in Table (5.1) to prove that the model have sustained oscillation solution with a
period of 120min.
5.2 The Spatio-temporal Model
We now extend the above model and consider spatial interactions within the cell:
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Figure 5.2: Representative oscillatory profiles of Hes1 mRNA and Hes1 protein resulting from
a simulation of the model using the parameters listed in Table 5.1.
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Figure 5.3: Plot showing the limit cycle obtained from the 5-variable model.
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∂ [y1n]
∂ t = Dy1n∇
2[y1n]−µ1[y1n]+ k1
[
1
(1+α[y4n])n
]
, (5.6)
∂ [y1c]
∂ t = Dy1c∇
2[y1c]−µ1[y1c], (5.7)
∂ [y3c]
∂ t = Dy3c∇
2[y3c]−µ3[y3c]+ k3[y1c]−2k4[y3c]2, (5.8)
∂ [y4c]
∂ t = Dy4c∇
2[y4c]−µ4[y4c]+ k4[y3c]2, (5.9)
∂ [y4n]
∂ t = Dy4n∇
2[y4n]−µ4[y4n], (5.10)
where, y1n, y1c, y3c, y4c and y4n represent Hes1 mRNA in the nucleus, mRNA in the
cytoplasm, Hes1 monomer in the cytoplasm, Hes1 dimer in the cytoplasm and Hes1
dimer in the nucleus respectively. µ1, µ3 and µ4 are the liner degradation of Hes1
mRNA, Hes1 monemar and Hes1 dimer respectively. Also, k1, k3, k4 and α are the
rate of mRNA production hes1 protein production, dimer formation and Hes1 protein
production respectively.
As previously the continuity of flux boundary conditions for the nucleus membrane
allow import and export of mRNA and the protein and zero flux boundary condition at
the cytoplasm membrane to ensure that all molecules remain within the cell membrane
i.e.
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Dy1n
∂ [y1n]
∂n = Dy1c
∂ [y1c]
∂n and [y1n] = [y1c] at the nuclear membrane (5.11)
Dy3c
∂ [y3c]
∂n = 0 and [y3c] = 0 at the nuclear membrane (5.12)
Dy4n
∂ [y4n]
∂n = Dy4c
∂ [y4c]
∂n and [y4n] = [y4c] at the nuclear membrane (5.13)
∂ [y1c]
∂n = 0, at the cell membrane (5.14)
∂ [y3c]
∂n = 0, at the cell membrane (5.15)
∂ [y4c]
∂n = 0, at the cell membrane (5.16)
Equations (5.6)–(5.10) represent a system of reaction-diffusion equations modelling
the spatio-temporal evolution of the more detailed Hes1 system. The same reaction
kinetics from the ODE model of Momiji and Monk (2008) are retained but are now
also coupled with diffusion to model explicitly protein and mRNA transport within a
cell, i.e., molecules move from the nucleus to the cytoplasm and cytoplasm to nucleus
across the nuclear membrane. The PDE system reflects the reality that mRNA is tran-
scribed from DNA exclusively in the nucleus and that protein is translated from mRNA
exclusively in the cytoplasm. Finally, we make the assumption that the dimerization
of proteins in the cytoplasm occurs some distance away from the nucleus and it takes
more time for the Hes1 dimer protein to shuttle to the nucleus.
∂ [y3c]
∂ t = Dy3c∇
2[y3c]−µ3[y3c]+ k3H1(x,y)[y1c]−2k4[y3c]2 (5.17)
where H1(x,y) is a function localising the protein production whose specific form will
be given after the nondimensionalisation of the system.
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We nondimensionalise Equations (5.6), (5.7), (5.9), (5.10) and (5.18) with scaling vari-
ables as follows (see appendix C):
[y∗1n] =
[y1n]
y0
, [y∗1c] =
[y1c]
y0
, [y∗3c] =
[y3c]
y0
, [y∗4n] =
[y4n]
y0
, [y∗4c] =
[y4c]
y0
(5.18)
t∗ =
t
τ
,X∗ =
x
L
,Y ∗ =
y
L
(5.19)
where [y0] is reference concentration, τ is reference time, and L is a reference length.
Using this scaling Equations (5.6), (5.7), (5.9), (5.10) and (5.18) become:
∂ [y1n]∗
∂ t∗ = D
∗
y1n∇
2[y1n]∗−µ∗1 [y1n]∗+ k∗1
(
1
1+α∗[y4n]∗
)
(5.20)
∂ [y1c]∗
∂ t∗ = D
∗
y1c∇
2[y1c]∗−µ∗1 [y1c]∗ (5.21)
∂ [y3c]∗
∂ t∗ = D
∗
y3c∇
2[y3c]∗−µ∗3 [y3c]∗+ k∗3H1(x,y)[y1c]∗−2k∗4[y3c]∗2 (5.22)
∂ [y4c]∗
∂ t∗ = D
∗
y4c∇
2[y4c]∗−µ∗4 [y4c]∗+ k∗4[y3c]∗2 (5.23)
∂ [y4n]∗
∂ t∗ = D
∗
y4n∇
2[y4n]∗−µ∗4 [y4n]∗ (5.24)
where
τ
L2
Dy∗1n·y0 = D
∗
y1n ,
τ
L2
Dy∗1c·y0 = D
∗
y1c ,
τ
L2
Dy∗3c·y0 = D
∗
y3c
τ
L2
Dy∗4n·y0 = D
∗
y4n ,
τ
L2
Dy∗4c·y0 = D
∗
y4c , αy0 = α
∗
τµ1 = µ∗1 , τµ3 = µ∗3 , τµ4 = µ∗4
τk1
y0
= k∗1 , τk3 = k∗3 , τy0k4 = k∗4 (5.25)
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and
H1(x,y) =
 1, if x
2 + y2 > 0.3,
0, if x2 + y2 < 0.3.
We apply zero initial conditions, zero-flux boundary conditions at the cell membrane
and flux continuity boundary conditions across the nucleus membrane:
[y1n]∗ = [y4n]∗ = [y1c]∗ = [y3c]∗ = [y4c]∗ = 0, at t = 0 (5.26)
D∗y1n
∂ [y1n]∗
∂n = D
∗
y1c
∂ [y1c]∗
∂n and [y1n]
∗ = [y1c]∗ at the nuclear membrane(5.27)
D∗y4n
∂ [y4n]∗
∂n = D
∗
y4c
∂ [y4c]∗
∂n and [y4n]
∗ = [y4c]∗ at the nuclear membrane(5.28)
D∗y1c
∂ [y1c]∗
∂n = 0 and [y1c]
∗ = 0 at the nuclear membrane (5.29)
∂ [y1c]∗
∂n = 0, at the cell membrane (5.30)
∂ [y3c]∗
∂n = 0, at the cell membrane (5.31)
∂ [y4c]∗
∂n = 0, at the cell membrane (5.32)
We take reference concentrations to be [y0]=1µM. Figures 5.2, 5.3 show the simula-
tions results of Equations (5.20)–(5.24). It was recognisable that a period of oscillation
was approximately 225 time units. Hence, knowing that the period of oscillation of
Hes1 is approximately 2h (Hirata et al. 2003), we have the reference time τ as follows:
225τ = 2h which means τ= 32s (see appendix C).
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To obtain the value of the variable L, we used 2-dimensional cell with length of 30µM
to represents both the nucleus and cytoplasm where the nucleus has a major axis of
length 0.8 units and minor axis of length 0.5 units and the cytoplasm has a major axis
of length 3 units and a minor axis of length 2 units. Hence, the non-dimensional cell
width is equal to 3 L = 30µM so, the reference length L=10µM.
Parameter Estimation
The following parameter values were used in our simulations of the non-dimensional
Hes1 system:
D∗y1n = D
∗
y1c = D
∗
y3c = D
∗
y4n = D
∗
y4c = 7.5×10
−4
µ∗1 = µ∗3 = µ∗4 = 0.03
k∗1 = k∗3 = k∗4 = 5
α∗ = 1 , n∗ = 5 (5.33)
From 4.57 and 4.65 we calculate the dimensional parameter values (see appendix C):
Dy∗n =
L2D∗yn
τ
= 2.34×10−11cm2s−1
Dy∗1n = Dy1c∗ = Dy3c∗ = Dy4n∗ = Dy4c∗ = 2.34×10
−11cm2s−1
µ1 = µ3 = µ4 = 9.4×10−4s−1
k1 = k3 = k4 = 1.56×10−4
α = 1Ms−1. (5.34)
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5.2.1 Computational Simulation Results
Once again we solved PDE system (5.20)–(5.24) numerically using the finite element
software COMSOL (Triangular basis elements and Lagrange quadratic basis functions
along with a backward Euler time-stepping method for integrating the equations were
used in all simulations). Figure 5.4 shows the total concentrations of hes1 mRNA,
Hes1 protein dimers and Hes1 protein over time in the cytoplasm, while Figure 5.5
shows the total concentrations in the nucleus over time. Both sets of results show os-
cillatory dynamics of the Hes1 system. The plots presented in Figs. 5.6 and 5.7 show
how the hes1 mRNA and protein concentrations vary spatially as well as temporally
within the cell. The mRNA is produced inside the nucleus and by t = 50 min has started
to cross the nuclear membrane to enter the cytoplasm (Fig. 5.6). In the cytoplasm the
mRNA is translated into protein, then two Hes1 protein monomers bind to form a Hes1
dimer which then diffuses back into the nucleus and represses the production of its own
mRNA (t=250 min). The mRNA concentration has clearly depleted by t=120 min, re-
flecting the period of the temporal oscillation seen in Figs. 5.4, 5.5.
Figure 5.4: Plot of the concentrations of Hes1 mRNA (red), the Hes1 protein dimers (blue) and
Hes1 protein (green) in the cytoplasm over time. The period of oscillations is approximately
120 min
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Figure 5.5: Plot of the concentrations of hes1 mRNA (red) and Hes1 protein (green) in the
nucleus over time. The period of oscillations is approximately 120 min
5.3 External driving of Hes1 oscillation by Stat3 Phos-
phorylation
5.3.1 The Stat3 System
Stat3 (Signal Transducer and Activator of transcription) is a member of STATs pro-
teins that mediate cellular responses to different cytokines and growth factors. The
activation of STATs by tyrosine phosphorylation cytokines or growth factors bind to
the cell receptors. Once tyrosine phosphorylated, two STAT monomers form dimers.
The dimers then translocate to the nucleus and bind to specific region of the target
gene (Smithgall et al. 2000). Stat3 protein regulates gene expression involved in cell
proliferation, survival and self-renewal (Walker et al. 2011).
It was shown in previous study that formation of Stat3-P is inhibited in the absence
of Hes1, suggesting that Stat3-Socs3 oscillations and Hes1 oscillation depend on each
other. So, Hes proteins bind to JAK2 and Stat3 resulting of Stat3 phosphorylation and
activation. Phosphorylated Stat3 was detected only in the cells expressing Hes1, but
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Figure 5.6: Plots showing the spatio-temporal evolution of hes1 mRNA concentration within
the cell from times t = 0 to 450 min at 50 min intervals. The concentration oscillates in both
time and space. Parameter values as per (5.33).
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Figure 5.7: Plots showing the spatio-temporal evolution of Hes1 Protein concentration within
the cell from times t = 0 to 450 min at 50 min intervals. The concentration oscillates in both
time and space. Parameter values as per (5.33).
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not the surrounding cells where Hes1 expression markedly increases the level of ty-
rosine phosphorylation of endogenous Stat3. Suppression of Hes1 expression reduces
Stat3 phosphorylation (Kamakura et al. 2004). It has been found that Hes1 represses its
own expression by binding to its own promoter. Also, phosphorylated Stat3 (Stat3-P)
induces suppression of cytokine signaling 3 (Socs3) expression, Socs3 inhibits phos-
phorylation of Stat3 and negatively regulates it, forming a negative feedback loop.
Thus, the Stat-Socs pathway is regulated by its own negative feedback loop, in a sim-
ilar manner to Hes1 (Yoshiura et al. 2007). Interestingly, inhibition of Stat3-Socs3
oscillations blocks Hes1 oscillation, suggesting that Stat3- Socs3 signalling regulates
oscillatory versus persistent Hes1 expression (Yoshiura et al. 2007) (see Fig 5.9).
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Figure 5.8: Schematic diagram showing the similarity between the negative feedback loops in
the Hes1 and Stat3 systems.
5.3.2 The Stat3 Mathematical Model
To formulate the mathematical model of the intracellular regulatory system of the Stat3
negative feedback loop, we follow the same steps as in previous sections when deriving
the model of the Hes1 system. We suggest that Stat3 oscillatory expression plays a
central role in maintaining the segmentation clock. Stat3 represses the transcription of
its own gene through direct binding to regulatory sequences in the Stat3 promoter. The
basic interactions of this system (see Fig. 5.8 and 5.10), Stat3 protein is produced by
Stat3 mRNA and then goes on to inhibit its own mRNA and so forth, with the result
that the system oscillates with a period of around 120 min.
The equations governing the concentrations of Stat3 mRNA and protein respectively
are:
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Figure 5.9: Schematic diagram showing the constitutive activation of Stat3 by the cytokine
receptor JAK which phosphorylates Stat3, which is then dimerized and translocated to the
nucleus where it regulates gene expression. Stat3 signalling is phosphorylation-regulated by
SOCS3.
dSm
dt =
αSm
1+(Sp/P0)n
−µSmSm, (5.35)
dSp
dt = αSpSmc−µSpSp, (5.36)
where [Sm] and [Sp] are the concentration of Stat3 mRNA and Stat3 protein, respec-
tively.
The first term on the right hand side of Eq.(5.35) is a Hill function which decreases
as the protein concentration increases, modelling repression by the Stat3 protein. The
parameter αSm is the rate of transcript initiation in the absence of Stat3 protein and p0
is the concentration of Stat3 and n is a Hill coefficient. The second term represents the
natural degradation of the Stat3 mRNA with parameter µSm.
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Figure 5.10: A schematic representation of the Stat3 model
The first term on the right hand side of Eq.(5.36) is Stat3 protein production term from
translation of Stat3 mRNA with parameter αSp and the second term represents Stat3
protein degradation with parameter µSp.
We now extend the above ODE models and consider spatial interactions within the
cell. As previously, we consider the nucleus and cytoplasm as two distinct spatial com-
partments and the cytoplasm enclosed within the outer cell membrane. Transcription
occurs exclusively in the nucleus and protein synthesis occurs exclusively in the cyto-
plasm.We assume that the main mechanism governing the spatial movement of mRNA
and protein between the nucleus and cytoplasm is diffusion. Denoting by [Smn], [Smc]
and [Spn], [Spc] the concentrations of nuclear and cytoplasmic Stat3 mRNA and nu-
clear and cytoplasmic Stat3 protein, respectively, the system of equations describing
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the spatio-temporal evolution of Stat3 mRNA and Stat3 protein concentrations is now
∂Smn
∂ t = DSmn∇
2Smn +
αSm
1+(Sp/P0)n
−µSmSmn, (5.37)
∂Smc
∂ t = DSmc∇
2Smc−µSmSmc, (5.38)
∂Spc
∂ t = DSpc∇
2Spc +αSpSmc−µSpSpc, (5.39)
∂Spn
∂ t = DSpn∇
2Spn−µSpSpn. (5.40)
We apply zero initial conditions, zero-flux boundary condition at the cell membrane
and flux continuity boundary conditions across the nucleus membrane:
DSmn
∂ [Smn]
∂n = DSmc
∂ [Smc]
∂n and [Smn] = [Smc] at the nuclearmembrane
DSpn
∂ [Spn]
∂n = DSpc
∂ [Spc]
∂n and [Spn] = [Spc] at the nuclearmembrane
∂ [Smc]
∂n = 0, at the cell membrane
∂ [Spc]
∂n = 0, at the cell membrane (5.41)
5.3.3 Computational Simulation Results
As in the case of the Hes1 system, we solved the PDE system (5.37)-(5.40) numerically
using the parameter values in table (5.2). Fig 5.11 shows the total concentrations of
Stat3 mRNA and Stat3 protein over time in the nuclear compartment, while Fig 5.12
shows the total concentrations in the cytoplasm. Both sets of results show oscillatory
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dynamics of the Stat3 system.
Table 5.2: Parameters value used in the computational simulations of the PDE model
Parameters Values
µ1 0.03
µ2 0.03
α1 1
α2 1
n 5
p0 1
Figure 5.11: Plot of the concentration of Stat3 mRNA (red) and Stat3 protein (blue) in the
nucleus over time.
5.4 A Model of the Hes1-Stat3 system
As result of the study of the post translation oscillation of Stat3 phosphorylation and its
negative feedback loop which revealed a potential mechanism underlying the depen-
dency of Hes1 oscillation on the Stat3 phosphorylation oscillations, Momiji and Monk
(2008) incorporated these new features to study a Hes1 model which is based around
two components, then formulated a new ODE model including Hes1 dimerisation and
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Figure 5.12: Plot of the concentration of Stat3 mRNA (red) and Stat3 protein (blue) in the
cytoplasm over time.
time delays.
In this section we formulate the model in a different way while still incorporating the
time delay and Hes1 dimerisation.
90
∂y∗1n
∂ t∗ = D
∗
y1n∇
2y∗1n−µ∗1 y∗1n + k∗1
(
1
(1+α1∗y∗4n)n1
)
∂y∗1c
∂ t∗ = D
∗
y1c∇
2y∗1c−µ∗1 y∗1c
∂y∗3c
∂ t∗ = D
∗
y3c∇
2y∗3c−µ∗3 y∗3c + k∗3H1(x,y)y∗1c−2k∗4y∗23c
∂y∗4c
∂ t∗ = D
∗
y4c∇
2y∗4c−µ∗4 y∗4c + k∗4y∗23c
∂y∗4n
∂ t∗ = D
∗
y4n∇
2y∗4n−µ∗4 y∗4n
∂y5n
∂ t = Dy5n∇
2y5n +
α5
1+(y6n/P0)n2
−µ5y5n
∂y5c
∂ t = Dy5c∇
2y5c−µ5y5c
∂y6c
∂ t = Dy6c∇
2y6c +α6y6c−µ6y6c
∂y6n
∂ t = Dy6n∇
2y6n−µ6y6n (5.42)
Where, y1n, y1c, y3c, y4c, y4n, y5n, y5c, y6n and y6c represent Hes1 mRNA in the nu-
cleus, mRNA in the cytoplasm, Hes1 monomer in the cytoplasm, Hes1 dimer in the
cytoplasm, Hes1 dimer in the nucleus, Stat3 mRNA in the nucleus and Stat3 protein in
the cytoplasm, respectively. µ∗1 , µ∗3 and µ∗4 are the liner degradation of Hes1 mRNA,
Hes1 monomer and Hes1 dimer respectively. Also, k∗1, k∗3, and k∗4 are the rate of mRNA
production, hes1 protein production and dimer formation rate, respectively. Also α∗1 ,
α∗5 , α
∗
6 and n the prouduction of Hes1 mRNA in apsent of Hes1 protein, the rate of
Stat3 mRNA transcript, Stat3 protein production term and a Hill coefficient, respec-
tively.
Momiji and Monk (2008) showed a 120 min period oscillation in the level of phos-
phorylation of the Stat3 protein which was shown to be necessary for the observed
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Table 5.3: Parameters value
Parameters Values Parameters Values
p0 1 k1 2
µ1 0.03 k3 5
µ3 0.03 k4 2
µ4 0.03 α1 7
µ5 0.03 α5 1
µ6 0.03 α6 1
n1 2 n5 5
transcriptional Hes1 oscillations. Oscillation of Stat3 phosphorylation is driven by a
negative feedback loop involving Stat3 and Socs3 oscillation, and Hes1 oscillations
depend on the Stat3 phosphorylation oscillations (Yoshiura et al. 2007).
We ran numerical simulations of the Hes1-Stat3 system model using the parameter
values in table (5.3) to examine if there is any affect of each system on the other’s
oscillation when it does not have any time-dependent effects.
Figure 5.13 shows that Stat3 negative feedback oscillates and does not show any effect
caused by the Hes1 negative feedback while the Hes1 oscillations disappear. So Stat3
oscillations block the Hes1 oscillations. It is clear that Hes1 oscillations run normally
to prove that Stat3-Socs3 oscillations inhibit the Hes1 oscillations.
In the previous dimerisation model, the Hes1 dimers have a lower degradation rate than
Hes1 monomers. Momiji and Monk (2008) assumed that Stat3 has an equivalent effect
on the degradation of both monomeric and dimeric forms of Hes1 and so they set the
time dependent Hes1 protein degradation rate to observe the effect of oscillatory Stat3
on Hes1:
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µp = µ 8p +dµpsin(
2pit
T
) (5.43)
where µp is the decay rate of the protein and T is the period of Stat3 oscillation (120
min).
This functional form for the time dependence of the Hes1 protein degradation rate
was chosen to observe the effect of oscillatory Stat3 on Hes1, and plays the role of
a periodic forcing term in the equations describing Hes1 regulation. Therefore, we
modify our system by writing the Hes1 protein degradation rate µ3 ,µ4 as suggested
by Momiji and Monk (2008).
We assume that the degradation rate of Hes1 protein dimers µ3 have a lower degrada-
tion rate than Hes1 monomers µ4. Furthermore, we assume that Stat3 has an equivalent
effect on the degradation of both monomeric and dimeric forms of Hes1. We therefore
set the time-dependent Hes1 protein degradation rates to be:
µ3 = µ 83 +dµ3sin(
2pit
T
) (5.44)
µ4 = µ 84 +dµ4sin(
2pit
T
) (5.45)
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The equations for Hes1 and Stat3 are now:
∂y∗1n
∂ t∗ = D
∗
y1n∇
2y∗1n−µ∗1 y∗1n + k∗1
(
1
(1+α1∗y∗4n)n1
)
∂y∗1c
∂ t∗ = D
∗
y1c∇
2y∗1c−µ∗1 y∗1c
∂y∗3c
∂ t∗ = D
∗
y3c∇
2y∗3c− (µ 83 +dµ3sin(
2pit
T
))y∗3c + k∗3H1(x,y)y∗1c−2k∗4y∗23c
∂y∗4c
∂ t∗ = D
∗
y4c∇
2y∗4c− (µ 84 +dµ4sin(
2pit
T
))y∗4c + k∗4y∗23c
∂y∗4n
∂ t∗ = D
∗
y4n∇
2y∗4n− (µ 84 +dµ4sin(
2pit
T
))y∗4n
∂y5n
∂ t = Dy5n∇
2y5n +
α5
1+(y6n/P0)n2
−µ5y5n
∂y5c
∂ t = Dy5c∇
2y5c−µ5y5c
∂y6c
∂ t = Dy6c∇
2y6c +α6y6c−µ6y6c
∂y6n
∂ t = Dy6n∇
2y6n−µ6y6n (5.46)
5.4.1 Numerical Simulations
We apply zero initial conditions, zero-flux boundary condition at the cell membrane
and flux continuity boundary conditions across the nucleus membrane:
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Dy1n
∂ [y1n]
∂n = Dy1c
∂ [y1c]
∂n and [y1n] = [y1c] at the nuclear membrane
Dy3c
∂ [y3c]
∂n = 0 and [y3c] = 0 at the nuclear membrane
Dy4n
∂ [y4n]
∂n = Dy4c
∂ [y4c]
∂n and [y4n] = [y4c] at the nuclear membrane
Dy5n
∂ [y5n]
∂n = Dy5c
∂ [y5c]
∂n and [y5n] = [y5c] at the nuclear membrane
Dy6n
∂ [y6n]
∂n = Dy6c
∂ [y6c]
∂n and [y6n] = [y6c] at the nuclear membrane
∂ [y1c]
∂n = 0, at the cell membrane
∂ [y3c]
∂n = 0, at the cell membrane
∂ [y4c]
∂n = 0, at the cell membrane
∂ [y5c]
∂n = 0, at the cell membrane
∂ [y6c]
∂n = 0, at the cell membrane (5.47)
Fig 5.14 shows the results from a numerical simulation of the equation (5.45) when we
make the value of Hes1 dimer and monomer degradation rate a function of time.
In an extension to their original, basic model, Momiji and Monk (2008) considered the
parameters µ3 and µ4 as functions of Stat3 concentration. Arguing that Stat3 oscillated,
they then simply made these parameters depend on time in a sinusoidal manner as
follows:
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µ∗ = µ 8∗+dµ∗sin(
2pit
T
)
= 0.03+dµ∗sin(
2pit
T
)
(5.48)
with parameter values taken from the work of Yoshiura et al. (2007), dµp=1.1, µp=1.6
and µ 8p=1.9.
We now modify our system to make the parameters µ3 and µ4 explicitly depend on
Stat3 concentration (details given in Appendix A) and hence the modified equations
for Hes1 and Stat3 are:
∂y∗1n
∂ t∗ = D
∗
y1n∇
2y∗1n−µ∗1 y∗1n + k∗1
(
1
(1+α1∗y∗4n)n1
)
∂y∗1c
∂ t∗ = D
∗
y1c∇
2y∗1c−µ∗1 y∗1c
∂y∗3c
∂ t∗ = D
∗
y3c∇
2y∗3c− (µ 83 +(−0.004+0.00348∗ y6c)y∗3c + k∗3H1(x,y)y∗1c−2k∗4y∗23c
∂y∗4c
∂ t∗ = D
∗
y4c∇
2y∗4c− (µ 84 +(−0.004+0.00348∗ y6c)y∗4c + k∗4y∗23c
∂y∗4n
∂ t∗ = D
∗
y4n∇
2y∗4n− (µ 84 +(−0.004+0.00348∗ y6c)y∗4n
∂y5n
∂ t = Dy5n∇
2y5n +
α5
1+(y6n/P0)n2
−µ5y5n
∂y5c
∂ t = Dy5c∇
2y5c−µ5y5c
∂y6c
∂ t = Dy6c∇
2y6c +α6y6c−µ6y6c
∂y6n
∂ t = Dy6n∇
2y6n−µ6y6n (5.49)
Alternative equations for Hes1 and Stat3 where the parameters µ3 and µ4 explicitly
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depend on Stat3 concentration (details given in Appendix A) are:
∂y∗1n
∂ t∗ = D
∗
y1n∇
2y∗1n−µ∗1 y∗1n + k∗1
(
1
(1+α1∗y∗4n)n1
)
∂y∗1c
∂ t∗ = D
∗
y1c∇
2y∗1c−µ∗1 y∗1c
∂y∗3c
∂ t∗ = D
∗
y3c∇
2y∗3c− (µ 83 +(−0.015+0.00463∗ y6c)y∗3c + k∗3H1(x,y)y∗1c−2k∗4y∗23c
∂y∗4c
∂ t∗ = D
∗
y4c∇
2y∗4c− (µ 84 +(−0.015+0.00463∗ y6c)y∗4c + k∗4y∗23c
∂y∗4n
∂ t∗ = D
∗
y4n∇
2y∗4n− (µ 84 +(−0.015+0.00463∗ y6c)y∗4n
∂y5n
∂ t = Dy5n∇
2y5n +
α5
1+(y6n/P0)n2
−µ5y5n
∂y5c
∂ t = Dy5c∇
2y5c−µ5y5c
∂y6c
∂ t = Dy6c∇
2y6c +α6y6c−µ6y6c
∂y6n
∂ t = Dy6n∇
2y6n−µ6y6n (5.50)
Table 5.4: Parameters value
Parameters Values Parameters Values
D 7.5×10−4 α1 1
µ1 0.03 α5 1
µ3 0.03 α6 1
µ4 0.03 k1 2
µ5 0.03 k3 5
µ6 0.03 k4 2
dµ3 0.015 n1 2
dµ4 0.015 n5 5
T 200 p0 1
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5.5 Modelling Different Intracellular Phenomena
In this section we solve model (5.46) numerically to obtain the simulation result of the
system with some modifications representing possible intracellular phenomena that
could affect the spatio-temporal dynamics of the model. We first change the model
system to take account of the effect of adding noise to the diffusion in the cell and
examine the effect on the oscillations of the model.
Most physical systems which respond to the concentration of a signalling molecule
will exhibit noise due to the random movement of the molecules (diffusion) and vari-
ability in the processes of transcription and translation. Recent large scale surveys of
noise suggested that the noise in most protein levels can be understood in terms of
the components of noise that derive from the translation of mRNA into protein, or the
components that arise from noise in the transcription and degradation of the mRNA
itself (Gasper 2008).
To understand the effect that noise had on the oscillations of the intracellular network,
we add Gaussian Noise to our system by modifying the diffusion coefficient in the
Hes1-Stat3 System (5.45) i.e. D = D+ sin(0.01 ∗ t + awgn(sin(0.01 ∗ t),25))/5000)
(For the simulation result see Fig. 5.17).
We now consider a second change of the model system to examine the effect of adding
a nuclear membrane with zero flux boundary condition in the cell domain to the oscil-
lation of the model. A nuclear membrane is the double lipid bilayer membrane called
the inner membrane and the outer membrane which surrounds the genetic material and
divides the cell into two compartments (Martin 2010). During the intracellular signal
transaction the nucleus membrane control the diffusion from the cytoplasm through
98
the nucleus pore complex (NPC) to the nucleus and from the nucleus to the cytoplasm
(Weis 2003).
When the molecule binds to the surface of the outer membrane it can diffuse through
the nuclear pore and then diffuses into the inner membrane. The whole process takes
time which depends on the size of the molecule itself and the size of the nuclear
pore. Hence, larger molecules, such as proteins, will diffuse more slowly than smaller
molecules, such as mRNA (Sturrock et al. 2011).
To show the effect of the nuclear membrane on the oscillations of the Hes1-Stat3 sys-
tem, we consider the nuclear membrane to be of thickness d (which is also the depth
of the NPC of the nucleus membrane) in the system of equations (5.46). The nuclear
membrane thickness has been estimated to be approximately 100nm (Sturrock et al.
2011). Also, we assume that diffusion across it is slower than in the cytoplasm or nu-
cleus, with protein diffusion slower than mRNA diffusion across the membrane. We
simply choose Dm = Di j/5 and Dp = Di j/15 for the nuclear membrane diffusion for
mRNA for Hes1 and Stat3 and protein for Hes1 and Stat3, respectively (for the simu-
lation result see Fig. 5.18).
Finally we replace the previous continuity of flux boundary conditions with the fol-
lowing boundary conditions which considers the nuclear membrane thickness:
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Dy1n
∂ [y1n]
∂n =
Dy1([y1n]− [y1c])
d
Dy1c
∂ [y1c]
∂n =
Dy1([y1c]− [y1n])
d
Dy3c
∂ [y3c]
∂n =
Dy3([y3c]− [y3n])
d
Dy4n
∂ [y4n]
∂n =
Dy4([y1n]− [y4c])
d
Dy4c
∂ [y4c]
∂n =
Dy4([y1c]− [y4n])
d
Dy5n
∂ [y5n]
∂n =
Dy5([y5n]− [y1c])
d
Dy5c
∂ [y5c]
∂n =
Dy5([y5c]− [y1n])
d
Dy6n
∂ [y6n]
∂n =
Dy6([y1n]− [y6c])
d
Dy6c
∂ [y6c]
∂n =
Dy6([y1c]− [y6n])
d (5.51)
The boundary conditions (5.51) describe the flux across the nuclear membrane. This
flux can be thought of as a permeability coefficient (defined as the diffusion coefficient
of the species in the nuclear membrane divided by the membrane thickness) multiplied
by the concentration difference of the species across the nucleocytoplasmic boundary.
Next, we alter the composition of the cell cytoplasm to examine the effect of introduc-
ing some regions in the cytoplasm where molecular movement/transport is inhibited
for some reason and examine its effect on the oscillations of the model.
Finally we modify the model system to examine the effect of molecular convection
on the oscillations of the model. To achieve this, we consider active transport of the
proteins which is very important to shift the transcriptional factor quickly from the cy-
toplasm to the nucleus. Active transport of the proteins can be achieved by attachment
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to microtubules in the cytoplasm. The microtubules (MTs) are hollow cylindrical fila-
ments. During most of the life of the cell (interphase), the MTs are organized within
the cytoplasm as an aster originating from a microtubule organizing center (MTOC)
located in the proximity of the nucleus (Cangiani and Natalini 2010).
The role of MTs is that of enhancing intracellular trafficking. The size of macro-
molecules and intracellular organelles limits their diffusion speed to the cytoplasm, so
MTs resort with active transport in order to reach their target location. Active transport
is not essential to trafficking processes. Rather it must be seen as a way to improve
their efficiency. Active transport along the MTs is achieved by binding to a motor
protein, which possesses a mechanism for moving along the MT at a speed of about
0.5µms1 (Sturrock et al. 2012).
We shall model active transport of the transcription factor Hes1 as always being di-
rected towards the nucleus. We do this by adding a convection term to the cytoplasmic
Hes1 equation in equation system (5.45), which becomes:
∂y∗3c
∂ t∗ = D
∗
y3c∇
2y∗3c− (µ 83 +dµ3sin(
2pit
T
))y∗3c
+ k∗3y∗1c−∇ · (a[y3c])−2k∗4y∗23c , (5.52)
where −∇ · (a[y3c]) is active transport and a is the convective velocity given by
a = [
−ax√
x2 + y2
,
−ay√
x2 + y2
] (5.53)
and the parameter a is the convection speed.
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We run the simulation for the system of equations (5.46) and (5.52) while we still
considering the nuclear membrane effects.
Fig (5.17) shows the effect of adding a noise to the diffusion (D = D+ sin(0.01t +
awang(sin(0.01t),25)/5000), where D = 0.00075). The plot shows that all the vari-
ables of the model (Hes1 mRNA, Hes1 protein dimer, Hes1 protein, Stat3 mRNA and
Stat3 protein) have oscillations. By comparing the results of fig (5.18) to the original
simulation fig (5.14), we note the diffusion noise affects the concentration level of the
variables in the cytoplasm and causes some delay in the diffusion between the nucleus
and the cytoplasm. This result is similar to simulations of the system when we add a
nuclear membrane with width d and zero flux boundary condition in fig (5.18) where
the molecules take a longer time to move between the two parts of the domain.
In figs. (5.19) and (5.20) we consider the cell with a nuclear membrane. However
we also added some holes in the cytoplasm in fig (5.19) and considered convection
(i.e. motion along microtubules) in fig (5.20). In both figures we have oscillations but
in fig(5.19) the diffusion between the two domains still has the same delay while in
fig (5.20) convection helps to move the molecules faster between the nucleus and the
cytoplasm.
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Figure 5.13: Plots showing numerical solution of model (5.45) over time. Right figs show the
nucleus oscillation and the left figs show the cytoplasm oscillations. The red lines represent
the Hes1 mRNA (y1), the blue lines represent the Hes1 protein dimer (y3), the green lines
represent the Hes1 protein (y4), the black lines represent the Stat3 mRNA (y5), and the purple
lines represent the Stat3 protein (y6).
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Figure 5.14: Plots showing numerical solution of model (5.45) over time. The red lines repre-
sent the Hes1 mRNA (y1), the blue lines represent the Hes1 protein dimer (y3), the green lines
represent the Hes1 protein (y4), the black lines represent the Stat3 mRNA (y5), and the purple
lines represent the Stat3 protein (y6).
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Figure 5.15: Plots showing numerical solution of model (5.45) over time. The red lines repre-
sent the Hes1 mRNA (y1), the blue lines represent the Hes1 protein dimer (y3), the green lines
represent the Hes1 protein (y4), the black lines represent the Stat3 mRNA (y5), and the purple
lines represent the Stat3 protein (y6). The Figure shows the effect of remapping the value of
protein degradation rate in the model (5.45) with the new value present in eq.(5.47)
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Figure 5.16: Plots showing numerical solution of model (5.45) over time. The red lines repre-
sent the Hes1 mRNA (y1), the blue lines represent the Hes1 protein dimer (y3), the green lines
represent the Hes1 protein (y4), the black lines represent the Stat3 mRNA (y5), and the purple
lines represent the Stat3 protein (y6). The Fig show the affect of remapping the value of protein
degradation rate in the model (5.45) with the new value present in eq. (5.48).
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Figure 5.17: Plots showing n umerical solution of model (5.45) over time. The red lines
represent the Hes1 mRNA (y1), the blue lines represent the Hes1 protein dimer (y3), the green
lines represent the Hes1 protein (y4), the black lines represent the Stat3 mRNA (y5), and the
purple lines represent the Stat3 protein (y6). The plots show the effect of modifying the diffusion
D by adding white Gaussian noise D+awng and using it in the model (5.45).
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Figure 5.18: Plots showing Numerical solution of model (5.45) over time which is consider
the Nucleus membrane. The red lines represent the Hes1 mRNA (y1), the blue lines represent
the Hes1 protein dimer (y3), the green lines represent the Hes1 protein (y4), the black lines
represent the Stat3mRNA (y5), and the purple lines represent the Stat3 protein (y6).
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Figure 5.19: Plots showing Numerical solution of model (5.45) over time. The red lines repre-
sent the Hes1mRNA (y1), the blue lines represent the Hes1 protein dimer (y3), the green lines
represent the Hes1 protein (y4), the black lines represent the Stat3mRNA (y5), and the purple
lines represent the Stat3 protein (y6). The Fig show the affect of making some hole with zero
flux boundary condition in the cytoplasm.
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Figure 5.20: Plots showing Numerical solution of model (5.46) over time. The red lines repre-
sent the Hes1 mRNA (y1), the blue lines represent the Hes1 protein dimer (y3), the green lines
represent the Hes1 protein (y4), the black lines represent the Stat3mRNA (y5), and the purple
lines represent the Stat3 protein (y6). The model (5.46) show the effect of convection
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Chapter 6
Modelling the p53–Mdm2 System
6.1 A Spatio-Temporal Model of the p53-Mdm2 Sys-
tem
In this chapter we extend the previous model of the p53-Mdm2 system and consider
spatial interactions within the cell as shown in figure (4.13) in chapter 4. We consider
nucleus and cytoplasm domains as two spatial compartments separated by the nuclear
membrane and the cytoplasm has zero flux boundary condition with the out side cell
membrane. Also, we couple the reaction kinetics from ODE model (4.32), (4.33) and
(4.34) in chapter 4, with diffusion to model the protein and mRNA transport within the
cell.
p53 transcription takes place in the nucleus to produce p53 mRNA then transfers to the
cytoplasm where the p53 protein synthesis occurs and the same process goes with the
Mdm2 protein and Mdm2 mRNA. Then, we assume that the mechanism governing the
spatial movement of the mRNA and the protein between the nucleus and the cytoplasm
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is diffusion.
Therefore, we now consider the spatial interactions explicitly, allowing for diffusion
within the cell, and arrive at the following system of PDEs:
∂ [Pc]
∂ t = DPc∇
2[Pc]+H2(x,y)β − (µ +ν( [Mc]
h1
M̂h1 +[Mc]h1
))[Pc] (6.1)
∂ [Pn]
∂ t = DPn∇
2[Pn]− (µ +ν(
[Mn]h1
M̂h1 +[Mn]h1
))[Pn] (6.2)
∂ [Mmn]
∂ t = DMmn∇
2[Mmn]+α +η(
[Pn]h2
P̂h2 +[Pn]h2
)−φ [Mmn] (6.3)
∂ [Mmc]
∂ t = DMmc∇
2[Mmc]−φ [Mmc] (6.4)
∂ [Mc]
∂ t = DMc∇
2[Mc]+H1(x,y)γ[Mmc]−ρ [Mc] (6.5)
∂ [Mn]
∂ t = DM−n∇
2[Mn]−ρ [Mn] (6.6)
where ,[Pn], [Pc], [Mmn], [Mmc], [Mn] and [Mc] are the concentrations of the nuclear and
the cytoplasmic p53, the nuclear and the cytoplasmic Mdm2 mRNA and the nuclear
and the cytoplasmic Mdm2 protein respectively. [Di] denote the diffusion coefficients
for each species.
To model the transportation of both mRNA and the protein within the cell, we coupled
the ODE model (4.32), (4.33) and (4.34) with diffusion which enables us to model
the molecules moving from the nucleus to the cytoplasm and from the cytoplasm to
the nucleus across the nuclear membrane. Eqs.(6.1)-(6.6) represent a PDE system
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of reaction-diffusion equations modelling the spatio-temporal evolution of the p53-
Mdm2 system. H1(x,y) and H2(x,y) are functions localising the protein production
whose specific form will be given after the nondimensionalisation of the system.
We consider the continuity of flux boundary conditions for the nuclear membrane to
allow import and export of mRNA and the protein, and zero flux boundary conditions at
the cytoplasm membrane to ensure that all molecules remain within the cell membrane.
DPn
∂ [Pn]
∂n = DPc
∂ [Pc]
∂n and [Pn] = [Pc] at the nuclearmembrane (6.7)
DMmn
∂ [Mmn]
∂n = DMmc
∂ [Mmc]
∂n and [Mmn] = [Mmc] at the nuclearmembrane(6.8)
DMn
∂ [Mn]
∂n = DMc
∂ [Mc]
∂n and [Mn] = [Mc] at the nuclearmembrane (6.9)
∂ [Pc]
∂n = 0, at the cell membrane (6.10)
∂ [Mmc]
∂n = 0, at the cell membrane (6.11)
∂ [Mc]
∂n = 0, at the cell membrane (6.12)
where n is a unit normal.
We nondimensionalise Eqs. (6.1)-(6.6) with appropriate reference values as follows
(see Appendix D):
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[Pn] =
[Pn]
p0
, [Pc] =
[Pc]
p0
, [Mmn] =
[Mmn]
mm0
, [Mmc] =
[Mmc]
mm0
Mn] =
[Mn]
m0
, [Mc] =
[Mc]
m0
t =
t
τ
, X =
x
L
, Y =
y
L
(6.13)
where [p0] , [mm0] and [m0] are reference concentrations, τ is reference time, and L is
a reference length (10µm as with the Hes1 system). Using this scaling Eq. (6.1)-(6.6)
become:
∂ [Pc]
∂ t = D
∗
Pc∇2[Pc]+H2(x,y)β ∗− (µ∗+ν∗( [Mc]
h1
M∗+[Mc]h1
))[Pc] (6.14)
∂ [Pn]
∂ t = D
∗
Pn∇
2[Pn]− (µ∗+ν∗(
[Mn]h1
M∗+[Mn]h1
))[Pn] (6.15)
∂ [Mmn]
∂ t = D
∗
Mmn∇
2[Mmn]+α∗+η∗(
[Pn]h2
P∗+[Pn]h2
)−φ∗[Mmn] (6.16)
∂ [Mmc]
∂ t = D
∗
Mmc∇
2[Mmc]−φ∗[Mmc] (6.17)
∂ [Mc]
∂ t = D
∗
Mc∇
2[Mc]+H1(x,y)γ∗[Mmc]−ρ∗[Mc] (6.18)
∂ [Mn]
∂ t = D
∗
Mn∇
2[Mn]−ρ∗[Mn] (6.19)
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where
D∗Pn =
τDPn
L2
, D∗Pc =
τDPc
L2
D∗Mmn =
τDMmn
L2
, D∗Mmc =
τDMmc
L2
D∗Mn =
τDMn
L2
, D∗Mc =
τDMc
L2
M∗ =
M̂mh1
[Mm0]h1
, P∗ =
p̂h2
[P0]h2
β ∗ = τβ
p0
, η∗ = τη
mm0
µ∗ = τµ , ν∗ = τν
φ∗ = τφ , γ∗ = τγ[Mm0]
m0
, α∗ =
τα
mm0
ρ∗ = τρ (6.20)
and
H1(x,y) =
 0 if
x2
2 + y
2 ≤ 0.25,
1 if x22 + y
2 > 0.25.
and
H2(x,y) =

0 if x22 + y
2 ≤ 0.25,
1 if 0.25 < x22 + y
2 < 0.375,
0 if x22 + y
2 ≥ 0.375,
The function H1(x,y) is such that in a region close to the nucleus (representing the
location of the ER), the function is zero, meaning there is no protein synthesis in this
region. In a region further away from the nucleus (outside the ER) the function takes
the value of one, modelling the translation of protein in this region of the cytoplasm.
The function H2(x,y) is such that in a region close to the nucleus the function is zero,
meaning there is no protein synthesis here. However, it is now assumed that the func-
tion takes the value of one in an annular region outside of the ER (again modelling
the translation of protein). An annular region is chosen because we assume p53 is pro-
duced at a constant rate in the cytoplasm. This prevents p53 from being produced close
to the plasma membrane, where mRNA is unlikely to reach in sufficient quantities. The
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Figure 6.1: Schematic diagram showing the regions where the two functions H1(x,y) and
H2(x,y) are non-zero. The blue region of the cytoplasm depicts where we allow constant protein
synthesis to occur, i.e., this represents the rectangular function H2(x,y). The blue and red
regions together depict where we allow protein translation via mRNA, i.e., this represents the
function H1(x,y). In the white region representing the ER and nucleus, no protein synthesis
takes place.
two functions are illustrated graphically in Fig 6.1.
We apply zero initial conditions, zero-flux boundary conditions at the cell membrane
and flux continuity boundary conditions across the nuclear membrane:
[Pn] = [Pc] = [Mmn] = [Mmc] = [Mn] = [Mc] = 0, at t = 0 (6.21)
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D∗Pn
∂ [Pn]
∂n = D
∗
Pc
∂ [Pc]
∂n and [Pn] = [Pc] at the nuclearmembrane (6.22)
D∗Mmn
∂ [Mmn]
∂n = D
∗
Mmc
∂ [Mmc]
∂n and [Mmn] = [Mmc] at the nuclearmembrane(6.23)
D∗Mn
∂ [Mn]
∂n = D
∗
Mc
∂ [Mc]
∂n and [Mn] = [Mc] at the nuclearmembrane (6.24)
∂ [Pc]
∂n = 0, at the cell membrane (6.25)
∂ [Mmc]
∂n = 0, at the cell membrane (6.26)
∂ [Mc]
∂n = 0, at the cell membrane (6.27)
We take reference concentrations to be [P0] = 0.05,µM and estimated reference con-
centrations for [Mm0]=0.05µM and [M0]=2µM. Ma et al. (2005). Fig (6.1), (6.2) show
the simulations of Eqs.(6.14)-(6.19). It was noticed that the period of oscillation was
approximately 400 time units. Hence, knowing that the period of oscillation of p53
is approximately 3h Monk (2003), as result of this, we have the reference time τ as
follows: 400τ = 3 h which mean τ= 27 s.
Parameter estimation
The following parameter values were used in our simulations of the non-dimensional
p53-Mdm2 system:
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D∗Pc = D
∗
Pn = D
∗
Mmc = D
∗
Mmn = D
∗
Mc = D
∗
Mn = 9×10
−4
β ∗ = 0.5 , µ∗ = 0.003 , ν∗ = 1 , α∗ = 0.0175
η∗ = 1 , φ∗ = 0.0175. , γ∗ = 0.5 , ρ∗ = 0.025
h1 = 2 , h2 = 4 , M∗ = 16 , P∗ = 5 (6.28)
By using (6.20) and (6.28) to estimate the parameter values of the dimensional p53-
Mdm2 model (6.1)-(6.6).
DPc = DPn = DMmc = DMmn = DMc = DMn = 3.33×10−11cm2s−1
β = 9.26×10−3Ms−1 , µ = 1.11×10−4s−1
ν = 0.04s−1 , α = 3.24×10−11Ms−1
η = 1.85×10−9Ms−1 , φ = 6.48×10−4s−1
γ = 0.74s−1 , ρ = 9.26×10−4s−1
M̂ = 8×10−6M , P̂ = 7.48×10−7M
h1 = 2 , h2 = 4 (6.29)
6.2 Computational Simulation Results
Once again we solved the PDE system (6.14)(6.19) numerically using the finite ele-
ment package COMSOL/FEMLAB (with the same basis elements and basis functions
and time-stepping as previously). For all our simulations we used a 2-dimensional cell
domain of two ellipses to represent the nucleus and cytoplasm to show the oscillatory
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dynamics results of the P53-Mdm2 system.
Figs. (6.1) and (6.2) show the concentrations of p53 and Mdm2 in the nucleus and
cytoplasm. We can see from these p53 simulations that the mRNA concentration is
higher in the nucleus compared to the protein concentrations in the cytoplasm. while,
Mdm2 mRNA concentrations higher in the cytoplasm and Mdm2 protein is higher in
the nucleus.
Figure 6.2: Plots showing the concentrations of p53 (blue), Mdm2 mRNA (green) and Mdm2
(red) in the cytoplasm. The period of oscillations is approximately 180 min. Parameter values
as per (60).
Figs. (6.3), (6.4), and (6.5) show how the dynamics of the p53-Mdm2 system (evolve
in space as well as time) vary spatially throughout the cell over the period of the oscil-
lations in figures (6.1) and (6.2).
In Fig (6.3), we see that p53 has accumulated in the cytoplasm around t = 50, then
begins to diffuse across the nucleus membrane entering the nucleus by t = 100 while
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Figure 6.3: Plots showing the concentrations of p53 (blue), Mdm2 mRNA (green) and Mdm2
(red) in the nucleus. The period of oscillations is approximately 180 min. Parameter values as
per (60).
the Mdm2 mRNA in Fig (6.4) shows in the nucleus at the same time where the Mdm2
binds to the p53 to prevent p53 transcription. At t = 150 the Mdm2 shuttles p53 from
the nucleus to the cytoplasm for degradation, Fig(6.5). By time 400 the level of p53
begins to increase again in the cytoplasm. Figs. (6.4), (6.5) show the plots of Mdm2
concentration over time. In Fig (6.5) the Mdm2 protein is produced between t = 100
to t = 250 min, the same time as the Mdm2 mRNA is exported from the nucleus and
translation occurs in the cytoplasm.
In order to investigate the influence of spatial effects, we carried out number of simula-
tions on system (6.14)-(6.19), where we consider varying the thickness of the nuclear
membrane, varying the values of the diffusion coefficients of p53, Mdm2 protein and
Mdm2 mRNA, while all other parameters remaining unchanged and adding noise to
the diffusion coefficients.
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Figure 6.4: Plots showing the spatio-temporal evolution of p53 protein concentration within
the cell from times t = 0 to 450 min. The concentration oscillates in both time and space.
Parameter values as per (60).
6.3 Model extension incorporating the effect of the nu-
clear membrane
We now examine the effect of adding a nuclear membrane with zero flux boundary
condition in the cell domain to the oscillation of the model. A nuclear membrane is the
double lipid bilayer membrane called the inner membrane and outer membrane which
surrounds the genetic material and divides the cell into two compartments (Martin
2010). During the intracellular signal transaction the nuclear membrane controls the
diffusion from the cytoplasm through the nuclear pore complex (NPC) to the nucleus
and from the nucleus to the cytoplasm (Weis 2003).
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Figure 6.5: Plots showing the spatio-temporal evolution of Mdm2 mRNA concentration within
the cell from times t = 0 to 450 min. The concentration oscillates in both time and space.
Parameter values as per (60).
When the molecule binds to the surface of the outer membrane it can diffuse through
the nuclear pore and then diffuses into the inner membrane. The whole process takes
time which depends on the size of the molecule itself and the size of the nuclear
pore. Hence, larger molecules, such as proteins, will diffuse more slowly than smaller
molecules, such as mRNA (Sturrock et al. 2011).
To show the effect of the nuclear membrane on the oscillations of the p53-Mdm2 sys-
tem, we consider some additional points such as introducing a thickness d to the nu-
clear membrane (which is also the depth of the NPC of the nuclear membrane) to
122
Figure 6.6: Plots showing the spatio-temporal evolution of Mdm2 protein concentration within
the cell from times t = 0 to 450 min. The concentration oscillates in both time and space.
Parameter values as per (60).
equations (6.14)-(6.19). The nuclear membrane thickness has been estimated to be
approximately 100nm (Sturrock et al. 2011). Also, we assume that diffusion across it
is slower than in the cytoplasm or nucleus, with protein diffusion slower than mRNA
diffusion across the membrane. We simply choose Dm = Di j/5 and Dp = Di j/15 for
the nuclear membrane diffusion for mRNA for p53 and Mdm2 and protein for p53 and
Mdm2, respectively. Finally we replace the previous continuity of flux boundary con-
dition at the nuclear membrane with the following boundary condition which considers
the nuclear membrane thickness:
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DP53n
∂ [P53n]
∂n =
DP53([P53n]− [P53c])
d
DP53c
∂ [P53c]
∂n =
DP53([P53c]− [P53n])
d
DMdm2mn
∂ [Mdm2mn]
∂n =
DMdm2m([Mdm2mn]− [Mdm2mc])
d
DMdm2mc
∂ [Mdm2mc]
∂n =
DMdm2m([Mdm2mc]− [Mdm2mn])
d
DMdm2n
∂ [Mdm2n]
∂n =
DMdm2([Mdm2n]− [Mdm2c])
d
DMdm2c
∂ [Mdm2c]
∂n =
DMdm2([Mdm2c]− [Mdm2n])
d (6.30)
The boundary conditions (6.30) describe the flux across the nuclear membrane. This
flux can be thought of as a permeability coefficient (defined as the diffusion coefficient
of the species in the nuclear membrane divided by the membrane thickness) multiplied
by the concentration difference of the species across the nucleocytoplasmic boundary.
We ran the numerical simulation of the model system twice, the first one with no
change in the diffusion values (see Fig 6.7), while the second figure shows the effects
of nuclear membrane and the diffusion of the variables varies and are not equal (see
Figure 6.8).
The simulation result of Fig 6.7 and Fig 6.8 show clearly that the nuclear membrane
thickness could stop the diffusion of molecules between the two parts of the domain,
the nucleus and the cytoplasm.
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6.4 Modelling the effects of noise on the system
Most physical systems which respond to the concentration of a signalling molecule
will exhibit noise due to the random movement of molecules (diffusion) and delays
in the processes of transcription and translation. Recent large scale surveys of noise
suggested that the noise in most protein levels can be understood in terms of the com-
ponents of noise that derive from the translation of mRNA into protein, or the com-
ponents that arise from noise in the transcription and degradation of the mRNA itself
(Gasper 2008).
To understand the effect that noise coused to the oscillation of the intracellular net-
work, we add Gaussian Noise to the simulation code by modifying the diffusion coeffi-
cients in the p53-Mdm2 System (6.14)-(6.19) to D=D+sin(0.01∗t+awgn(sin(0.01∗
t),25))/5000.
We ran the numerical simulation of the model system twice. First with no change in the
diffusion values (see Fig 6.9), and second showing the effects of the nuclear membrane
and the diffusion coefficients of the variables not equal. (see Figure 6.10 ).
By comparing the simulation result of the p53-Mdm2 system including noise in the
molecular diffusion to the result of the main model system (6.30), we see clearly how
the noise caused the component concentration in the cytoplasm to reach a higher value
than in the nucleus where are the concentration is lower than the concentration in the
main model results, shown in Fig.6.2 and 6.3.
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Figure 6.7: Plots showing numerical simulation of model (6.14)-(6.19) over time. The red lines
represent the p53 (y1), the blue lines represent the Mdm2 mRNA (y2), the green lines represent
the Mdm2 protein (y3). The Fig shows the effect of considering the different nucleus membrane
thickness d values ( d=0.01, d=0.1, d=1 ), whereas the diffusion for the variables is equal.
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Figure 6.8: Plots showing numerical simulation of model (6.14)-(6.19) over time. The red lines
represent the p53 (y1), the blue lines represent the Mdm2 mRNA (y2), the green lines represent
the Mdm2 protein (y3). The Fig show the effect of considering the different nucleus membrane
thickness d values ( d=0.01, d=0.1, d=1 ), whereas the diffusion for the variables varies and is
not equal.
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Figure 6.9: Plots showing numerical simulation of model (6.14)-(6.19) over time. The black
lines represent the p53 (y1), the blue lines represent the Mdm2 mRNA (y2), the green lines
represent the Mdm2 protein (y3). The Fig show the effect of modifying the diffusion coefficient
D by adding additive white Gaussian noise D+awng. The diffusion for all variables is equal
and the nuclear membrane thickness = 0.01
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Figure 6.10: Plots showing numerical simulation of model (6.14)-(6.19) over time. The black
lines represent the p53 (y1), the blue lines represent the Mdm2 mRNA (y2), the green lines
represent the Mdm2 protein (y3). The Fig show the effect of modifying the diffusion D by
adding additive white Gaussian noise D+awng. The diffusion for the variables varies and is
not equal and the nucleus membrane thickness = 0.01
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Chapter 7
Conclusions and Future Work
We conclude this thesis with a brief summary of the major points and some possible
avenues of future exploration. Of course, this is by no means exhaustive, and we refer
the reader to the appropriate chapters for a more detailed account.
In the framework of this thesis we have studied the correct spatial localisation of tran-
scription factors where it is vitally important for the proper functioning of many intra-
cellular signalling pathways. Also we have showed that negative feedback loops are
important components of many intracellular signal transduction processes. In this the-
sis we have built on previous mathematical modelling approaches, and we have derived
systems of partial differential equations to capture the evolution in space and time of
the variables in the two pathways of the Hes1 and p53-Mdm2 feedback loops (gene
regulatory networks, GRN).
In the first model, we examined a detailed model of the Hes1 system, incorporating
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a number of basic biochemical processes neglected in previous models using a com-
bination of mathematical analysis and numerical simulation. We developed and ex-
tended the Hes1 model system of Momiji and Monk (2008) by using partial differen-
tial equations (PDEs) in order to be able to model the aspects of intracellular signalling
pathways. Also, we showed that Hes1 oscillations are in fact dependent on a post-
translational oscillation in the phosphorylation state of the protein Stat3. Oscillations
in the level of pStat3 provide an extrinsic driving force to the Hes1 auto-regulatory
network, by regulating the degradation rate of Hes1 protein (Yoshiura et al. 2007). We
have developed an extended model of the pStat3-driven Hes1 network by incorporat-
ing transcriptional delay and Hes1 dimerisation. However, simulation of the driven
network shows that the Hes1 network can respond to pStat3 oscillations by generating
oscillations in Hes1 mRNA and Hes1 protein without the inclusion of transcriptional
delay (Yoshiura et al. 2007).
The second model discussed in this thesis is a mathematical model of the p53-Mdm2
pathway where we use a system of PDEs to model the aspects this intracellular sig-
nalling pathway. The simulation results of our models demonstrated the existence of
oscillatory dynamics in negative feedback systems for the p53-Mdm2 pathways and
have been able to focus on reactions occurring both in the cell nucleus and in the cyto-
plasm.
In both the Hes1 and p53-Mdm2 systems, we varied the diffusion coefficients of the
mRNAs and proteins and found a range of values for these diffusion coefficients where
the system exhibits oscillatory dynamics. By varying the diffusion coefficients of
the molecules, we can vary the flux rates across the nuclear membrane (equivalent
to varying nuclear import and export rates), thus granting greater control and allow-
ing a much more in depth analysis of the systems. Similar results were obtained by
varying the mRNA degradation rates, protein degradation rates and Hill coefficients,
further demonstrating that the oscillations are robust to parameter changes. Exploiting
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the explicitly spatial nature of PDEs, we were also able to manipulate mathematically
the location of the ribosomes, thus controlling where the proteins were synthesized
within the cytoplasm. For both the Hes1 and the p53-Mdm2 systems, we carried out
a number of numerical simulations where we investigated the effect of varying the
two functions H1(x,y) and H2(x,y), controlling constant protein synthesis and protein
translation via mRNA in the cytoplasm, respectively. For both model systems, the
simulation results revealed an optimum distance outside the nucleus for protein pro-
duction for which sustained (undamped) oscillations of large amplitude were observed.
Future work arising from this thesis could extend the current models by considering
the active transport of proteins and mRNA within the cell as mechanisms of move-
ment in addition to diffusion (Cangiani and Natalini 2010). One could also model the
nuclear membrane in more detail and take into account its thickness. This would al-
low one to model differences in the rate of transport of mRNA and protein across the
nuclear membrane more accurately. Additional complexities of post-transcriptional
mRNA and post-translational protein modifications could also be examined. Future
models with the developments just noted, would enable us to drill down into the fun-
damental differences between cancer cells and normal cells. As an exemplar, using
the p53-Mdm2 pathway we would be able to model the effects of different therapeutic
approaches, including the temporal and spatial distributions of targeted disruption of
p53 or Mdm2 interactions by non-genotoxic mechanisms.
Finally, one could consider extending the Hes1 GRN in some detail using the spa-
tial stochastic models in various ways. In particular, one could investigate nuclear
transport in more detail and begin to account for the ran-cycle. Many transcription fac-
tors are known to be actively transported towards the nucleus along microtubules and
this aspect of intracellular molecular transport should be investigated in more detail
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(Lomakin and Nadezhdina 2010). One should also conduct a global sensitivity anal-
ysis of the model using data clustering techniques. One may also consider cell-cell
communication in future work to see if this acts to stabilise and synchronise oscilla-
tory behaviour as Masamizu et al. (2006) found. Naturally, our approach is readily
applicable to many other pathways and future work should also investigate the intri-
cacies of the p53-Mdm2 negative feedback loop in more detail and perhaps consider
pathway cross-talk e.g. interactions with other gene regulatory networks such as the
NF-κB pathway.
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Appendix
Appendix A
The Non-Dimensional Hes1 System:
∂ [Mn]
∂ t = DMn∇
2[Mn]+
αM
1+( [Pn]p̂ )h
−µM [Mn]
∂ [Mc]
∂ t = DMc∇
2[Mc]−µM[Mc]
∂ [Pc]
∂ t = DPc∇
2[Pc]+αP[Mc]−µP[Pc]
∂ [Pn]
∂ t = DPn∇
2[Pn]−µP[Pn] (7.1)
Nondimensionalisation: Reference concentrations: m0, p0
Reference time: τ (the period of oscillation in the Hes1 system)
Reference length: L (0.4 times the length of a cell)
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Normalising variables in terms of appropriate reference parameters:
[Mn] = [Mn]m0 , [Mc] = [Mc]m0
t = tτ , x = LX , y = LY (7.2)
Nondimensionalise the 5 equations using the scaling variables:
first equation:
∂ [Mn]
∂ t = DMn∇
2[Mn]+
αM
1+( [Pn]p̂ )h
−µM[Mn]
∂ [Mn]
∂ t =
∂m0·[Mn]
∂ t = m0
[Mn]
∂ t ·
∂ t
∂ t =
m0
τ
·
∂ [Mn]
∂ t (7.3)
DMn∇2[Mn] = DMn·m0
(
∂ 2m0 · [Mn]
∂x2 +
∂ 2m0 · [Mn]
∂y2
)
= DMn·m0
 ∂
∂x
(
∂m0 · [Mn]
∂x
)
+
∂
∂y
(
∂m0 · [Mn]
∂y
)
= DMn·m0
( ∂
∂X ·
∂X
∂x
)(
∂m0 · [Mn]
∂X ·
∂X
∂x
)
+
(
∂
∂Y ·
∂Y
∂y
)(
∂m0 · [Mn]
∂Y ·
∂Y
∂y
)
= DMn·m0
( ∂
∂X ·
1
L
)(∂m0 · [Mn]
∂X ·
1
L
)
+
( ∂
∂Y ·
1
L
)(∂m0 · [Mn]
∂Y ·
1
L
)
= DMn·m0
m0
L2
(
∂ 2[Mn]
∂X 2
)
+
m0
L2
(
∂ 2[Mn]
∂Y 2
)
= DMn·m0
m0
L2
·
(
∂ 2
∂X
2 +
∂ 2
∂Y
2
)
· [Mn]
=
m0
L2
DMn·m0∇
2[Mn] (7.4)
(
[Pn]
p̂
)h = (
p0[Pn]
p̂
)h , [Mn] = [Mn]m0 (7.5)
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So the equation has the new form:
m0
τ
·
∂ [Mn]
∂ t =
m0
L2
DMn·m0∇
2[Mn]+
αM
1+( p0[Pn]p̂ )h
−µM·[Mn]
∂ [Mn]
∂ t =
τ
L2
DMn·m0∇
2[Mn]+
τ
m0
αM
1+( p0[Pn]p̂ )h
−
τµM·
m0
[Mn] (7.6)
Where
τ
L2
DMn·m0 = D
∗
Mn
,
τµM·
m0
= µ∗M ,
ταM
m0
= α∗M , p
∗ =
p0
p̂
(7.7)
Also similarly:
D∗Mc =
τ
L2
DMc·m0 , D
∗
Pn
=
τ
L2
DPn·p0 , D
∗
Pc
=
τ
L2
DPc·p0
µ∗P =
τµP·
p0
, α∗P =
ταP
p0
(7.8)
The following parameter values were used in our simulations of the non-dimensional
Hes1 system:
D∗Mn = D
∗
Mc = D
∗
Pn = D
∗
Pc = 7.5×10
−4
α∗M = 1 , α∗P = 2 , h = 5 , p∗ = 1 , µ∗M = µ∗P = 0.03 (7.9)
∂
(
[Mn]m0
)
∂ (tτ) =
DMn
L2
∇2[Mn]m0 +
αM
1+( [Pn]p0p̂ )h
−µM [Mn]m0
∂
(
[Mc]m0
)
∂ (tτ) =
DMc
L2
∇2[Mc]m0−µM[Mc]m0
∂
(
[Pc]p0
)
∂ (tτ) =
DPc
L2
∇2[Pc]p0 +αP[Mc]−µP[Pc]p0
∂
(
[Pn]p0
)
∂ (tτ) =
DPn
L2
∇2[Pn]p0−µP[Pn]p0 (7.10)
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∂ [Mn]
∂ t =
(
τDMn
L2
)
∇2[Mn]+
(
ταM
m0
)
1+( [Pn]p0p̂ )h
− (τµM) [Mn]
∂ [Mc]
∂ t =
(
τDMc
L2
)
∇2[Mc]− (τµM) [Mc]
∂ [Pc]
∂ t =
(
τDPc
L2
)
∇2[Pc]+
(
τm0αP
p0
)
[Mc]− (τµP) [Pc]
∂ [Pn]
∂ t =
(
τDPn
L2
)
∇2[Pn]− (τµP) [Pn] (7.11)
∂ [Mn]
∂ t = D
∗
Mn∇
2[Mn]+
α∗M
1+(p∗[Pn])h
−µ∗M[Mn]
∂ [Mc]
∂ t = D
∗
Mc∇
2[Mc]−µ∗M[Mc]
∂ [Pc]
∂ t = D
∗
Pc∇
2[Pc]+α∗P[Mc]−µ∗P[Pc]
∂ [Pn]
∂ t = D
∗
Pn∇
2[Pn]−µ∗P[Pn] (7.12)
Where
D∗Mn =
τDMn
L2
, D∗Mc =
τDMc
L2
, D∗Pn =
τDPn
L2
, D∗Pc =
τDPc
L2
α∗M =
ταM
[m0]
, α∗P =
τ[m0]αP
[p0]
µ∗M = τµM , µ∗P = τµP , p∗ =
p0
p̂
(7.13)
As a first approximation we assume all diffusion coefficients are equal.
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Calculating the effective diffusion coefficient, D:
L = 10µm
= 10×10−6m
= 10×10−4cm (7.14)
200τ = 2hrs
τ =
7200s
200
= 36s (7.15)
D∗ =
τD
L2
D =
L2D∗
τ
=
10×10×
(
10−6
)2
m2×D∗
τ
=
10×10×
(
10−4
)2
cm2×D∗
τ
=
100×10−8cm2×D∗
τ
=
1×10−6cm2×7.5×10−4
36s
= 2.0833333333×10−11cm2s−1 (7.16)
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Calculating the transcription rate αM.
m0 = 0.05µm
τ = 36s
α∗M =
ταM
m0
αM =
m0α∗M
τ
=
0.05×10−6M×1
36s
= 1.388888889×10−9ms−1 (7.17)
Calculating the repression threshold, p̂:
p∗ =
p0
p̂
p̂ =
p0
p∗
=
1×10−6m
1
= 1×10−6m (7.18)
Calculating the degradation rate of hes1 mRNA, µM :
τ = 36s
µ∗M = τµM
µM =
µ∗M
τ
=
0.03
36s
= 8.3333333×10−4s−1 (7.19)
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Calculating the translation rate, αP:
m0 = 0.05µm
p0 = 1µm
τ = 36s
α∗P =
τ[m0]αP
[p0]
αP =
α∗P[p0]
τ[m0]
=
2×1×10−6m
0.05×10−6m×36s
= 1.11111111111s−1 (7.20)
Calculating the degradation rate of Hes1 protein, µP:
τ = 36s
µ∗P = τµP
µP =
µ∗P
τ
=
0.03
36s
= 8.3333333×10−4s−1 (7.21)
Appendix B
Functional Dependence of the Parameters µ3 and µ4 on Stat3 Concentration
In this section we provide details of how we modified the parameters µ3 and µ4 to
have them explicitly depend on the concentration of Stat3. This was done to match
the model extension of Momiji and Monk (2008) where the two parameters µ3 and µ4
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were oscillatory values over time.
Figure 7.1: Plot of the total concentration of Stat3 showing the maximum and minimum values
which are used to modify the parameters µ3 and µ4.
Figure 7.2: Plot of the Stat3 concentration use to map to the parameters µ3 and µ4
We made the parameters µ3 and µ4 functions of Stat3 concentration (i.e. to ensure both
parameters varied over time in an oscillatory manner as per Stat3 concentration, but to
also ensure they remained positive) via a simple mapping as follows:
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[5.475,14.1] −→ [−0.015,0.015]
µ = a+b∗Stat3
0.015 = a+b∗14.1
−0.015 = a+b∗5.475
0.03 = 8.625∗b
b = 0.00348
a = −0.034 (7.22)
So
µ = a+b∗ y6c
= −0.034+0.00348∗ y6c
µ = 0.03−0.034+0.00348∗ y6c
= −0.004+0.00348∗ y6c
(7.23)
Figure 7.3: Plot of the Stat3 concentration use to map to the parameters µ3 and µ4
Once again we made the parameters µ3 and µ4 functions of Stat3 concentration (i.e. to
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ensure both parameters varied over time in an oscillatory manner as per Stat3 concen-
tration, but to also ensure they remained positive) via a simple mapping as follows:
[5.475,14.1] −→ [−0.02,0.02]
µ = a+b∗Stat3
0.02 = a+b∗14.1
−0.02 = a+b∗5.475
0.04 = 8.625∗b
b = 0.00463
a = −0.045 (7.24)
So
µ = a+b∗ y6c
= −0.045+0.00463∗ y6c
µ = 0.03−0.045+0.00463∗ y6c
= −0.015+0.00463∗ y6c
(7.25)
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Appendix C
The Non-Dimensional Hes1 System Extended model:
∂ [y1n]
∂ t = Dy1n∇
2[y1n]−µ1[y1n]+ k1
[
1
(1+[y4n])n
]
∂ [y1c]
∂ t = Dy1c∇
2[y1c]−µ1[y1c]
∂ [y3c]
∂ t = Dy3c∇
2[y3c]−µ3[y3c]+ k3[y1c]−2k4[y3c]2
∂ [y4c]
∂ t = Dy4c∇
2[y4c]−µ4[y4c]+ k4[y3c]2
∂ [y4n]
∂ t = Dy4n∇
2[y4n]−µ4[y4n] (7.26)
scaling variables:
y∗1n =
y1n
y0
, y∗1c =
y1c
y0
, y∗3c =
y3c
y0
, y∗4n =
y4n
y0
, y∗4c =
y4c
y0
t∗ =
t
τ
, X∗ =
x
L
, Y ∗ =
y
L
(7.27)
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So:
∂y1n
∂ t = Dy1n∇
2y1n−µ1y1n + k1[
1
1+ y4n
]
∂y1n
∂ t =
∂y0·y∗1n
∂ t = y0
∂y∗1n
∂ t∗ ·
∂ t∗
∂ t =
y0
τ
·
∂y∗1n
∂ t∗
Dy1n∇2y1n = Dy∗1n·y0
(
∂ 2y0 · y∗1n
∂x2 +
∂ 2y0 · y∗1n
∂y2
)
= D
(
∂
∂x
(∂y0 · y∗1n
∂x
)
+
∂
∂y
(∂y0 · y∗1n
∂y
))
= Dy∗1n·y0
(( ∂
∂X∗ ·
∂X∗
∂x
)(∂y0 · y∗1n
∂X∗ ·
∂X∗
∂x
)
+
( ∂
∂Y ∗ ·
∂Y ∗
∂y
)(∂y0 · y∗1n
∂Y ∗ ·
∂Y ∗
∂y
))
= Dy∗1n·y0
(( ∂
∂X∗ ·
1
L
)(∂y0 · y∗1n
∂x∗ ·
1
L
)
+
( ∂
∂Y ∗ ·
1
L
)(∂y0 · y∗1n
∂Y ∗ ·
1
L
))
= D
 y0
L2
(
∂ 2y∗1n
∂X∗2
)
+
y0
L2
(
∂ 2y∗1n
∂Y ∗2
)
= D
y0
L2
·
(
∂ 2
∂X∗2
+
∂ 2
∂Y ∗2
)
· y∗1n
=
y0
L2
Dy∗1n·y0∇
2y∗1n (7.28)
y0
τ
·
∂y∗1n
∂ t∗ =
y0
L2
Dy∗1n·y0∇
2y∗1n−µ1·y∗1n + k1
(
1
1+αy0 · y∗4n
)
∂y∗1n
∂ t∗ =
τ
L2
Dy∗1n·y0∇
2y∗1n−
τµ1·
y0
y∗1n +
τk1
y0
(
1
1+αy0 · y∗4n
)
∂y∗1n
∂ t∗ = D
∗
y1n∇
2y∗1n−µ∗1 y∗1n + k∗1
(
1
1+α∗y∗4n
)
(7.29)
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y0
τ
∂y∗1n
∂ t∗ =
y0
L2
Dy∗1n·y0∇
2y∗1n− y0µ1y∗1n + k1
(
1
1+ y0αy∗4n
)
y0
τ
∂y∗1c
∂ t∗ =
y0
L2
Dy∗1c·y0∇
2y∗1c− y0µ1y∗1c
y0
τ
∂y∗3c
∂ t∗ =
y0
L2
Dy∗3c·y0∇
2y∗3c−µ3y∗3c + k3y∗1c−2k4y∗23c
y0
τ
∂y∗4c
∂ t∗ =
y0
L2
Dy∗4c·y0∇
2y∗4c− y0µ4y∗4c + y20k4y∗23c
y0
τ
∂y∗4n
∂ t∗ =
y0
L2
Dy∗4n·y0∇
2y∗4n− y0µ4y∗4n (7.30)
∂y∗1n
∂ t∗ =
τ
L2
Dy∗1n·y0∇
2y∗1n− τµ1y∗1n +
τk1
y0
(
1
1+ y0αy∗4n
)
∂y∗1c
∂ t∗ =
τ
L2
Dy∗1c·y0∇
2y∗1c− τµ1y∗1c
∂y∗3c
∂ t∗ =
τ
L2
Dy∗3c·y0∇
2y∗3c− τµ3y∗3c + τk3y∗1c−2τy0k4y∗23c
∂y∗4c
∂ t∗ =
τ
L2
Dy∗4c·y0∇
2y∗4c− τµ4y∗4c + τy0k4y∗23c
∂y∗4n
∂ t∗ =
τ
L2
Dy∗4n·y0∇
2y∗4n− τµ4y∗4n (7.31)
∂y∗1n
∂ t∗ = D
∗
y1n∇
2y∗1n−µ∗1 y∗1n + k∗1
(
1
1+α∗y∗4n
)
∂y∗1c
∂ t∗ = D
∗
y1c∇
2y∗1c−µ∗1 y∗1c
∂y∗3c
∂ t∗ = D
∗
y3c∇
2y∗3c−µ∗3 y∗3c + k∗3y∗1c−2k∗4y∗23c
∂y∗4c
∂ t∗ = D
∗
y4c∇
2y∗4c−µ∗4 y∗4c + k∗4y∗23c
∂y∗4n
∂ t∗ = D
∗
y4n∇
2y∗4n−µ∗4 y∗4n (7.32)
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Where,
τ
L2
Dy∗1n·y0 = D
∗
y1n ,
τ
L2
Dy∗1c·y0 = D
∗
y1c ,
τ
L2
Dy∗3c·y0 = D
∗
y3c
τ
L2
Dy∗4n·y0 = D
∗
y4n ,
τ
L2
Dy∗4c·y0 = D
∗
y4c , αy0 = α
∗
τµ1 = µ∗1 , τµ3 = µ∗3 , τµ4 = µ∗4
τk1
y0
= k∗1 , τk3 = k∗3 , τy0k4 = k∗4 (7.33)
The following parameter values were used in our simulations of the non-dimensional
Hes1 system:
D∗y1n = D
∗
y1c = D
∗
y3c = D
∗
y4n = D
∗
y4c = 7.5×10
−4
µ∗1 = µ∗3 = µ∗4 = 0.03
k∗1 = k∗3 = k∗4 = 5
α∗ = 1 , n∗ = 5 (7.34)
As a first approximation we assume all diffusion coefficients are equal.
Calculating the effective diffusion coefficient, D:
L = 10µm
= 10×10−6m
= 10×10−4cm (7.35)
225τ = 2hrs
τ =
7200s
225 = 32s (7.36)
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D∗ =
τD
L2
D =
L2D∗
τ
=
10×10×
(
10−6
)2
m2×D∗
τ
=
10×10×
(
10−4
)2
cm2×D∗
τ
=
100×10−8cm2×D∗
τ
=
1×10−6cm2×7.5×10−4
32s
= 2.34375×10−11cm2s−1 (7.37)
Calculating the degradation rates, µ1,µ3 and µ4
µ1 = µ3 = µ4
τ = 32s
µ∗ = τµ
µ = µ
∗
τ
=
0.03
32s
= 9.4×10−4s−1 (7.38)
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Calculating the production rates, k1,k3 and k4
τk1
y0
= k∗1 , τk3 = k∗3 , τy0k4 = k∗4
k1 =
y0k∗1
τ
, k3 =
k∗3
τ
, k4 =
k∗4
τy0
y0 = 1mµ
k1 =
y0k∗1
τ
=
1×5
32s−1
= 1.56×10−1s−1
k3 =
k∗3
τ
=
1×5
32s−1
= 1.56×10−1s−1
k4 =
k∗4
τy0
=
1×5
32s−1
= 1.56×10−1s−1
α∗ = y0α
α =
α∗
y0
= 1ms−1 (7.39)
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Appendix D
The Non-Dimensional P53-Mdm2 System:
∂ [Pc]
∂ t = DPc∇
2[Pc]+β − (µ +ν( [Mc]
h1
M̂h1 +[Mc]h1
))[Pc] (7.40)
∂ [Pn]
∂ t = DPn∇
2[Pn]− (µ +ν(
[Mn]h1
M̂h1 +[Mn]h1
))[Pn] (7.41)
∂ [Mmn]
∂ t = DMmn∇
2[Mmn]+α +η(
[Pn]h2
P̂h2 +[Pn]h2
)−φ [Mmn] (7.42)
∂ [Mmc]
∂ t = DMmc∇
2[Mmc]−φ [Mmc] (7.43)
∂ [Mc]
∂ t = DMc∇
2[Mc]+ γ[Mmc]−ρ [Mc] (7.44)
∂ [Mn]
∂ t = DM−n∇
2[Mn]−ρ [Mn] (7.45)
Where ,[Pn] , [Pc] , [Mmn] ,[Mmc] , [Mn] and [Mc] are the concentration of the nu-
clear and the cytoplasmic P53, the nuclear and the cytoplasmic Mdm2 mRNA and the
nuclear and the cytoplasmic Mdm2 protein respectively.[Di] denote the diffusion coef-
ficients for each species.
We nondimensionalise equations with appropriate reference values as follows:
[Pn] =
[Pn]
p0
, [Pc] =
[Pc]
p0
, [Mmn] =
[Mmn]
mm0
, [Mmc] =
[Mmc]
mm0
Mn] =
[Mn]
m0
, [Mc] =
[Mc]
m0
t =
t
τ
, X =
x
L
, Y =
y
L
(7.46)
Where [p0] , [mm0] and m0] are reference concentration, τ is reference time, and L is a
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reference length (10µmas with Hes1 system).
∂ [Pc]
∂ t = p0
∂
[
Pc
]
∂ t∗ ·
∂ t∗
∂ t =
p0
τ
·
∂
[
Pc
]
∂ t∗
DPn∇2Pn = DPn·p0
(
∂ 2 p0 ·Pn
∂x2 +
∂ 2 p0 ·Pn
∂y2
)
= DPn·p0
 ∂
∂x
(
∂ p0 ·
[
Pn
]
∂x
)
+
∂
∂y
(
∂ p0 ·
[
Pn
]
∂y
)
= DPn·p0
( ∂
∂X ·
∂X
∂x
)(
∂ p0 ·
[
Pn
]
∂X ·
∂X
∂x
)
+
(
∂
∂Y ·
∂Y
∂y
)(
∂ p0 ·
[
Pn
]
∂Y ·
∂Y
∂y
)
= DPn·p0
( ∂
∂X ·
1
L
)(∂ p0 · [Pn]
∂X ·
1
L
)
+
( ∂
∂Y ·
1
L
)(∂ p0 · [Pn]
∂Y ·
1
L
)
= DPn·p0
 p0
L2
(
∂ 2
[
Pn
]
∂X2
)
+
p0
L2
(
∂ 2
[
Pn
]
∂Y 2
)
= DPn·p0
p0
L2
·
(
∂ 2
∂X2
+
∂ 2
∂Y 2
)
·Pn
=
p0
L2
DPn·p0∇
2Pn (7.47)
As well:
∂ [Pc]
∂ t =
p0
τ
·
∂
[
Pc
]
∂ t∗ ,
∂ [Pn]
∂ t =
p0
τ
·
∂
[
Pn
]
∂ t∗
∂ [Mmc]
∂ t =
mm0
τ
·
∂
[
Mmc
]
∂ t∗ ,
∂ [Mmn]
∂ t =
mm0
τ
·
∂
[
Mmn
]
∂ t∗
∂ [Mc]
∂ t =
m0
τ
·
∂
[
Mc
]
∂ t∗ ,
∂ [Mn]
∂ t =
m0
τ
·
∂
[
Mn
]
∂ t∗ (7.48)
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1∂ [Pc]
∂ t = DPc∇
2[Pc]+β − (µ +ν( [Mc]
h1
M̂h1 +[Mc]h1
))[Pc]
p0
τ
·
∂
[
Pc
]
∂ t∗ =
p0
L2
DPc·p0∇
2Pc +β − (µ +ν( ([Mc]m0)
h1
M̂h1 +([Mc]m0)h1
))([Pc]p0)
∂
[
Pc
]
∂ t∗ =
τ
L2
DPn·p0∇
2Pc +
τ
p0
β − (τµ +(τν)( ([Mc]m0)
h1
M̂h1 +([Mc]m0)h1
))([Pc])
∂
[
Pc
]
∂ t∗ =
τ
L2
DPn·p0∇
2Pc +
τ
p0
β − (τµ +(τν)( [Mc]
h1(
M̂
m0
)h1
+[Mc]h1
))([Pc])
∂
[
Pc
]
∂ t∗ = D
∗
Pn·
∇2Pc +β ∗− (µ∗+ν∗( [Mc]
h1
M∗h1 +[Mc]h1
))([Pc]) (7.49)
2
∂ [Pn]
∂ t = DPn∇
2[Pn]− (µ +ν(
[Mn]h1
M̂h1 +[Mn]h1
))[Pn]
p0
τ
·
∂
[
Pn
]
∂ t∗ =
p0
L2
DPn·p0∇
2Pn− (µ +ν(
([Mc]m0)h1
M̂h1 +([Mc]m0)h1
))([Pn]p0)
∂
[
Pn
]
∂ t∗ =
τ
L2
DPn·p0∇
2Pn− (τµ +(τν)(
([Mc]m0)h1
M̂h1 +([Mc]m0)h1
))([Pn])
∂
[
Pn
]
∂ t∗ =
τ
L2
DPn·p0∇
2Pn− (τµ +(τν)(
[Mc]h1(
M̂
m0
)h1
+[Mc]h1
))([Pn])
∂
[
Pn
]
∂ t∗ = D
∗
Pn·
∇2Pn− (µ∗+ν∗(
[Mc]h1
M∗h1 +[Mc]h1
))([Pn]) (7.50)
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3∂ [Mmn]
∂ t = DMmn∇
2[Mmn]+α +η(
[Pn]h2
P̂h2 +[Pn]h2
)−φ [Mmn]
mm0
τ
·
∂
[
Mmn
]
∂ t∗ =
mm0
L2
DMmn·mm0∇
2 [Mmn]+α +η( (p0[Pn])h2
P̂h2 +(p0[Pn])h2
)−φ([Mmn]mm0)
mm0
τ
·
∂
[
Mmn
]
∂ t∗ =
τ
L2
DMmn·mm0∇
2 [Mmn]+ τ
mm0
α +
τ
mm0
η( (p0[Pn])
h2
P̂h2 +(p0[Pn])h2
)− τφ [Mmn]
∂
[
Mmn
]
∂ t∗ =
τ
L2
DMmn·mm0∇
2 [Mmn]+ τ
mm0
α +
τ
mm0
η( [Pn]
h2(
P̂
p0
)h2
+[Pn]h2
)− τφ [Mmn]
∂
[
Mmn
]
∂ t∗ = D
∗
Mmn·
∇2
[
Mmn
]
+α∗+η ∗ ( [Pn]
h2
p∗h2 +[Pn]h2
)− τφ [Mmn] (7.51)
4
∂ [Mmc]
∂ t = DMmc∇
2[Mmc]−φ [Mmc]
mm0
τ
·
∂
[
Mmc
]
∂ t∗ =
mm0
L2
DMmc·mm0∇
2 [Mmc]−φ([Mmc]mm0)
∂
[
Mmc
]
∂ t∗ =
τ
L2
DMmc·mm0∇
2 [Mmc]− τφ [Mmc]
∂
[
Mmc
]
∂ t∗ = D
∗
Mmc·
∇2
[
Mmc
]
−φ∗ [Mmc] (7.52)
5
∂ [Mc]
∂ t = DMc∇
2[Mc]+ γ[Mmc]−ρ [Mc]
m0
τ
·
∂
[
Mc
]
∂ t∗ =
m0
L2
DMc·m0∇
2 [Mc]+ γ([Mmc]mm0)−ρ([Mc]m0)
∂
[
Mc
]
∂ t∗ =
τ
L2
DMc·m0∇
2 [Mc]+ τ
m0
γ([Mmc]mm0)−
τ
m0
ρ([Mc]m0)
∂
[
Mc
]
∂ t∗ =
τ
L2
DMc·m0∇
2 [Mc]+ τmm0
m0
γ[Mmc]− τρ [Mc]
∂
[
Mc
]
∂ t∗ = D
∗
Mc·
∇2
[
Mc
]
+ γ∗[Mmc]−ρ∗[Mc] (7.53)
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6∂ [Mn]
∂ t = DM−n∇
2[Mn]−ρ [Mn]
m0
τ
·
∂
[
Mn
]
∂ t∗ =
m0
L2
DMn·m0∇
2 [Mn]−ρ([Mn]m0)
∂
[
Mn
]
∂ t∗ =
τ
L2
DMn·m0∇
2 [Mn]− τ
m0
ρ([Mn]m0)
∂
[
Mn
]
∂ t∗ =
τ
L2
DMn·m0∇
2 [Mn]− τρ [Mn]
∂
[
Mn
]
∂ t∗ = D
∗
Mn·
∇2
[
Mn
]
+ γ∗[Mmn]−ρ∗[Mn] (7.54)
where
D∗Pn =
τDPn
L2
, D∗Pc =
τDPc
L2
D∗Mmn =
τDMmn
L2
, D∗Mmc =
τDMmc
L2
D∗Mn =
τDMn
L2
, D∗Mc =
τDMc
L2
M∗ =
M̂mh1
[Mm0]h1
, P∗ =
p̂h2
[P0]h2
β ∗ = τβ
p0
, η∗ = τη
mm0
µ∗ = τµ , ν∗ = τν
φ∗ = τφ , γ∗ = τγ[Mm0]
m0
, α∗ =
τα
mm0
ρ∗ = τρ (7.55)
The following parameter values were used in our simulations of the non-dimensional
P53-Mdm2 system:
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D∗Pc = D
∗
Pn = D
∗
Mmc = D
∗
Mmn = D
∗
Mc = D
∗
Mn = 9×10
−4
β ∗ = 0.5 , µ∗ = 0.003 , ν∗ = 1 , α∗ = 0.0175
η∗ = 1 , φ∗ = 0.0175. , γ∗ = 0.5 , ρ∗ = 0.025
h1 = 2 , h2 = 4 , M∗ = 16 , P∗ = 5 (7.56)
Calculating the effective diffusion coefficient, D:
L = 10µm
= 10×10−6m
= 10×10−4cm (7.57)
400τ = 3hrs
τ =
10800s
400 = 27s (7.58)
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D∗ =
τD
L2
D =
L2D∗
τ
=
10×10×
(
10−6
)2
m2×D∗
τ
=
10×10×
(
10−4
)2
cm2×D∗
τ
=
100×10−8cm2×D∗
τ
=
1×10−6cm2×9×10−4
27s
= 0.33333333×10−10cm2s−1
= 3.3333333×10−11cm2s−1 (7.59)
Calculating the production rate of P53, β :
p0 = 0.05µm =⇒ p0 = 0.05×10−6M
τ = 27s
β ∗ = τ
p0
β
β = p0β
∗
τ
=
0.05×10−6M×0.5
27s
= 0.000925939×10−6Ms−1
= 9.25939×10−10Ms−1 (7.60)
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Calculating the degradation rate of P53, µ:
µ∗ = τµ
µ = µ
∗
τ
=
0.003
27s
= 1.11×10−4s−1 (7.61)
Calculating the degradation rate of P53 dependent on Mdm2 concentration, ν:
ν∗ = τν
ν =
ν∗
τ
=
1
27s
= 0.03703704s−1
= 0.04s−1 (7.62)
Calculating the natural transcription rate of Mdm2 mRNA, α:
mm0 = 0.05µm
α∗ =
τα
mm0
α =
mm0α∗
τ
=
0.05×10−6M×0.0175
27s
= 0.00003241×10−6Ms−1
= 3.241×10−11Ms−1 (7.63)
Calculating the enhanced natural transcription rate of Mdm2 mRNA dependent on the
157
concentration of P53, η:
mm0 = 0.05µm
η∗ = τη
mm0
η = mm0η
∗
τ
=
0.05×10−6M×1
27s
= 0.00185185×10−6Ms−1
= 1.85×10−9Ms−1 (7.64)
Calculating the natural degradation rate of Mdm2 mRNA, φ :
φ∗ = τφ
φ = φ
∗
τ
=
0.0175
27s
= 0.00064815s−1
= 6.4815×10−4s−1 (7.65)
Calculating the translation rate of Mdm2, γ:
mm0 = 0.05µm
m0 = 2µm
γ∗ = τγmm0
m0
γ = m0γ
∗
τmm0
=
0.5×2×10−6M
0.05×10−6M×27s
= 0.740s−1 (7.66)
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Calculating the natural degradation rate of Mdm2, ρ
ρ∗ = τρ
ρ = ρ
∗
τ
=
0.025
27s
= 0.00092593s−1
= 9.2593×10−4s−1 (7.67)
Calculating the activation threshold of P53 degradation dependent on Mdm2, M̂dm2 :
M̂ :
m0 = 2µm
h1 = 2
M∗ =
M̂
m20
2
M̂ =
√
M∗×m20
M̂ =
√
16× (2µm)2
= 8×10−6µM (7.68)
Calculating the activation threshold for transcription of Mdm2 mRNA dependent on
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P53,P̂53 : P̂ :
p0 = 0.5µm
h2 = 4
P∗ =
P̂
p40
4
P̂ = 4
√
P∗× p40
= 4
√
5× (0.5µm)4
= 0.74×10−7µM (7.69)
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